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Public health initiatives include vaccination and screening efforts to reduce the burden of 
disease. This study addressed colorectal cancer (CRC) screening behaviors of 
accountable care organization (ACO) patients with different social determinants of health 
and providers’ ability to comply with the Medicare Shared Savings Plan (MSSP) quality 
measure ACO #19. This study followed the socioecological model and a cross-sectional 
quantitative design to assess data from the MSSP public use file 2019 across three 
manuscripts to expand on current literature. The purpose was to determine whether 
patient behavior was the primary driver to improve healthcare quality. Study results 
showed that performance rates increased in ACOs that had a greater number of patients. 
ACOs with more non-White patients and more Medicaid patients were less successful 
with CRC screening. Performance was highest when more patients were between 65-85 
years of age as compared to patients under 65 or over 85 years old. The implications for 
positive social change in this study include data for policy makers, health, and public 
health care professionals to reduce disparities for CRC screening and incidence of CRC 
among vulnerable populations. The data also support population health initiatives beyond 




The Relationship Between Advanced Payment Model Providers and Patient Behavior 
by 
Harry B. Petaway III 
 
 
MPA, Western Michigan University, 2001 
BS, Western Michigan University, 1997 
 
 
Dissertation Submitted in Partial Fulfillment 
of the Requirements for the Degree of 









I dedicate this dissertation to my wife, mother, brother, sister, and late father. 
Your love and support are my inspiration for social change. I dedicate this work to my 
teachers, coaches, and professors for grounding me with a work ethic that was invaluable 
during the dissertation process. Lastly, I dedicate this work to the members of my 
diversity, equity and inclusion resource group and all aspiring change agents focused on 




I acknowledge my family by blood and other for their outstanding support, 
motivation, and encouragement. I acknowledge the faculty and staff of Walden 
University who guided me on my doctoral journey. A humble thank you to my 
chairperson Dr. Jeanne Connors and committee member Dr. Peter Anderson for your 
relentless support. Lastly a special thank you to my URR Dr. Vasileios Margaritis for 





Table of Contents 
List of Tables .................................................................................................................... vii 
List of Figures .................................................................................................................. viii 
Part 1: Overview ..................................................................................................................1 
Introduction ....................................................................................................................1 
Problem ................................................................................................................... 3 
Contribution to Social Change ................................................................................ 3 
Background ....................................................................................................................4 
Key Variables and Alignment ................................................................................. 7 
Conceptual Framework ........................................................................................... 9 
Overview of the Manuscripts .......................................................................................10 
Manuscript 1 ......................................................................................................... 11 
Manuscript 2 ......................................................................................................... 13 
Manuscript 3 ......................................................................................................... 14 
Significance..................................................................................................................16 
Policy ................................................................................................................... 17 
Social Change ....................................................................................................... 18 
Summary ......................................................................................................................19 
Part 2: Manuscripts ............................................................................................................20 
The Relationship Between Advanced Payment Model Providers and Patient 
Behavior: Practice Size and Provider Influence on Patient Behavior ..............20 





Problem ................................................................................................................. 23 
Significance of the Study ...................................................................................... 24 
Framework ............................................................................................................ 26 
Background ........................................................................................................... 27 
Research Questions and Design ............................................................................ 32 
Methods........................................................................................................................33 
Operational Definitions ......................................................................................... 33 
Bias and Limitations ............................................................................................. 33 
Scope and Delimitations ....................................................................................... 34 
Design ................................................................................................................... 35 
Instrumentation ..................................................................................................... 35 
Participants ............................................................................................................ 36 
Data Sources ......................................................................................................... 36 
Results ..........................................................................................................................37 
Execution .............................................................................................................. 37 
Descriptive Statistics for all ACOs ....................................................................... 38 
Tests of Assumptions ............................................................................................ 40 
Inferential Statistics Manuscript 1 ........................................................................ 41 




Interpretation ......................................................................................................... 44 
Interpretation in the Context of the Socioecological Model ................................. 45 
Limitations ............................................................................................................ 46 
Implications........................................................................................................... 46 
Recommendations ................................................................................................. 48 
Conclusion ...................................................................................................................49 
References ....................................................................................................................52 
Provider Influence on Patient Behavior Related the Population’s Race, Age, 
and Gender .......................................................................................................64 
Outlet for Manuscript ...................................................................................................65 
Abstract ........................................................................................................................66 
Introduction ..................................................................................................................67 
Problem ................................................................................................................. 67 
Significance of the Study ...................................................................................... 68 
Framework ............................................................................................................ 69 
Background ........................................................................................................... 71 
Research Question and Design ............................................................................. 75 
Methods........................................................................................................................76 
Operational Definitions ......................................................................................... 76 
Bias and Limitations ............................................................................................. 77 
Scope and Delimitations ....................................................................................... 77 
Design ................................................................................................................... 78 
 
iv 
Instrumentation ..................................................................................................... 78 
Participants ............................................................................................................ 79 
Data Sources ......................................................................................................... 80 
Results ..........................................................................................................................80 
Execution .............................................................................................................. 81 
Descriptive Statistics for all ACOs ....................................................................... 82 
Tests of Assumptions ............................................................................................ 84 
Inferential Statistics Manuscript 2 ........................................................................ 85 
Linear Regression ................................................................................................. 88 
Discussion ....................................................................................................................89 
Interpretation ......................................................................................................... 89 
Interpretation in the Context of the Socioecological Model ................................. 90 
Limitations ............................................................................................................ 91 
Implications........................................................................................................... 92 
Recommendations ................................................................................................. 93 
Conclusion ...................................................................................................................94 
References ....................................................................................................................97 
Provider Influence on Patient Behavior Related to Population Insurance 
Coverage ........................................................................................................110 





Problem ............................................................................................................... 113 
Significance of the Study .................................................................................... 114 
Framework .......................................................................................................... 116 
Background ......................................................................................................... 117 
Research Question and Design ........................................................................... 122 
Methods......................................................................................................................123 
Operational Definitions ....................................................................................... 123 
Bias and Limitations ........................................................................................... 124 
Scope and Delimitations ..................................................................................... 124 
Design ................................................................................................................. 125 
Instrumentation ................................................................................................... 125 
Participants .......................................................................................................... 126 
Data Sources ....................................................................................................... 127 
Results ........................................................................................................................127 
Execution ............................................................................................................ 128 
Percent of Medicaid Patients .....................................................................................128 
Descriptive Statistics for all ACOs ..................................................................... 129 
Tests of Assumptions .......................................................................................... 130 
Inferential Statistics ............................................................................................ 131 
Linear Regression ............................................................................................... 133 
Discussion ..................................................................................................................133 
Interpretation ....................................................................................................... 133 
 
vi 
Interpretation in the Context of the Socioecological Model ............................... 134 
Limitations .......................................................................................................... 135 
Implications......................................................................................................... 135 
Recommendations ............................................................................................... 137 
Conclusion .................................................................................................................138 
References ..................................................................................................................141 
Part 3: Summary ..............................................................................................................154 






List of Tables 
Table 1. Variables and Statistical Tests Used to Evaluate Research Questions ............... 38 
Table 2. ACO #19 Performance Range and Frequency .................................................... 39 
Table 3. Range and Frequency of Primary Care Providers in ACOs ............................... 39 
Table 4. Range and Percentage of Attributions Across All ACOs ................................... 40 
Table 5. Range and Percentage of Attribution .................................................................. 40 
Table 6. Correlation Between ACO #19 Performance and Practice Size ......................... 43 
Table 7. Variables and Statistical Tests Used to Evaluate Research Questions ............... 82 
Table 8. ACO #19 Performance Range and Frequency .................................................... 82 
Table 9. Range and Frequency of Primary Care Providers in ACOs ............................... 83 
Table 10. Range and Percentage of Attributions Across all ACOs .................................. 84 
Table 11. Range and Percentage of Attribution ................................................................ 84 
Table 12. Correlation Between Attribution Age and Performance ................................... 86 
Table 13. Correlation Between Attribution Race and CRC Screening ............................. 88 
Table 14. Variables and Statistical Tests Used to Evaluate Research Questions ........... 128 
Table 15. ACO #19 Performance Range and Frequency ................................................ 129 
Table 16. Range and Percentage of Attribution Across all ACOs .................................. 129 
Table 17. Range and Percentage of Attribution .............................................................. 130 
Table 18. Correlation Between Medicaid and ACO #19 Performance………………...130 
 
viii 
List of Figures 
Figure 1. Normal Q-Q Plot for ACO #19 Performance .................................................... 41 
Figure 2. ACO Practice Size Attribution .......................................................................... 42 
Figure 3. Normal Q-Q Plot for ACO #19 Performance .................................................... 85 
Figure 5. Normal Q-Q Plot for ACO #19 Performance .................................................. 131 






Part 1: Overview  
Introduction 
Health care delivery and public health have overlapping goals to improve health 
outcomes in their communities through vaccination and screening. The paths toward 
these goals are influenced by factors like policies, funding sources, and external demands 
that guide community-based organizations’ and health care and public health 
organizations’ decisions (Cunningham et al., 2020). To address rising healthcare costs in 
the United States (Shrank et al., 2019) as well as significant disparities in health 
outcomes across the population (Foo et al., 2017), public, community, and clinical health 
professionals in several communities have partnered to form organizations designed to 
improve public health by addressing social determinants of health and influencing 
individual behavior (Bachrach et al., 2016; Noble et al., 2014). For example, the Institute 
of Healthcare Improvement’s Quadruple Aim outlined a framework to improve health 
outcomes, lower healthcare costs, improve patient experience, and improve clinician 
satisfaction (Wagner et al., 2018). Experimental alternative payment delivery models 
(APM) were created with varying success to influence components of the Quadruple Aim 
(Noble et al., 2014).  
Additionally, population engagement can lead to behaviors that result in healthier 
outcomes, which may also reduce the overall cost of care (Grand et al., 2014; Simmons et 
al., 2014). Two population-based behaviors intended to reduce the burden of disease 
include vaccinations and screenings (Siewert et al., 2020). Over 34,000 Americans died 
from influenza during the 2018–2019 influenza season, which included nearly 500,000 
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hospitalizations and an estimated 35.5 million people who became sick; however, the 
general rate of behavior adoption for influenza vaccinations in the United States is less 
than 50%, with rates among people aged 65 year and older approximately 65% (Centers 
for Disease Control and Prevention [CDC], 2019). But physicians are often the first line 
of defense to promote the behaviors that influence public health (Redwood et al., 2016). 
Another example of population-based behavior is colon cancer screening. In 
2016, colorectal cancer (CRC) was the third leading cancer diagnosed for U.S. citizens, 
excluding skin cancers, with an estimated 40,000 deaths attributed to colon cancer 
(Bachman et al., 2018). Individuals who are overweight, use alcohol, smoke, practice 
risky sex, and are physically inactive are at higher risk of CRC (Bachman et al., 2018). 
These risks are influenced by individuals’ behavior; however, CRC screening can provide 
early identification of CRC and improve health outcomes (Bachman et al., 2018). But 
there are significant differences in CRC screening rates across, racial, and 
sociodemographic populations (Bachman et al., 2018). Cancer screening rates have also 
declined due to the COVID-19 pandemic especially for minority populations, which is 
expected to lead to increase cancer for all populations (Carethers et al., 2020). Before the 
pandemic, physicians enrolled in accountable care organizations (ACOs) were measured 
on the success rate of CRC screening for their patients through the performance measure 
ACO #19 of the standards of the Medicare Shared Savings Plan (MSSP) for CRC 
Screening (Smith et al., 2019). Medicare recognized four methods of CRC screening that 
vary in complexity and invasiveness: fecal immunochemical test, fecal occult blood test, 




Health care delivery and public health have overlapping efforts like health 
screening activities to lower the burden of disease (Cunningham et al., 2020). Though 
patient behavior is the key to improve quality and health outcomes, there are barriers to 
influence individual behavior (Morge et al., 2019). Moreover, there are disparities in 
compliance among people with health behavior recommendations based on factors like 
age, gender, insurance coverage, and the size of their providers’ practices (Kiviniemi et 
al., 2018; Manteuffel et al., 2014). Data on the patient experience are abundant and 
available through performance reporting, from sources like the Centers for Medicare and 
Medicaid Services (CMS, n.d.), and patient perspectives toward patient engagement are 
well documented in the literature (Rowland et al., 2017). However, provider success and 
strategies to engage community members attributed to their APMs has not been 
comprehensively explored (Andrealli et al., 2018; Bekmuratova et al., 2019; Berenson et 
al., 2016; Chen et al., 2016). Thus, there is an inability to replicate best practices for 
population engagement, which could improve health outcomes, participant experiences, 
lower costs, and improve job satisfaction.  
Contribution to Social Change 
Partnerships between community-based organizations, health care delivery, and 
public health organizations improve public health outcomes (Cunningham et al., 2020). 
My study addressed the gap in research by focusing on providers’ abilities to influence 
APM participant behavior. The results may contribute to positive social change by 
providing meaningful data to public health partnerships that impact community health 
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outcomes. Thus, my study could improve the ability to influence the behaviors and health 
outcomes of the community members they serve.  
Background 
ACOs are one of the APMs designed to alter the reimbursement of healthcare 
services from a traditional fee-for-service structure to a value-based care model. The 
initial performance under the Medicare ACO model reduced healthcare expenditures 
within the attributed population base when compared to traditional Medicare fee-for-
service beneficiaries (Nywelde et al., 2015). CMS measures ACO providers across four 
domains: care coordination, patient safety, patient experience, and preventative health 
(Mod et al., 2018). Providers are rewarded for the decreased cost of patient care and 
achievement of various quality metrics outlined in their ACO contracts. Studies have 
shown that many healthcare providers including those in underserved areas saw ACOs as 
a means to achieve greater quality while improving population health (Bekmuratova et 
al., 2019; Berenson et al., 2016). Furthermore, some organizations believed that 
improving health outcomes outweighed financial incentives (Phipps-Taylor & Shortell, 
2016). Conversely, some providers avoided ACO membership because they did not have 
the infrastructures or collaborative relationships in place to succeed (Bekmuratova et al., 
2019), though there has been growing emphasis on preventative care and more 
collaboration between healthcare providers and traditional public health organizations 
(Ingram et al., 2015). This is particularly true for cancer prevention initiatives (Basch et 
al., 2016).  
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CRC is a leading cause of death in the United States and can be reduced with 
early detection (Lloyd, 2016). However, almost 25% of adults between 76 and 84 did not 
meet the U.S. Preventative Services Task Force recommendations for CRC screening 
before the advent of Medicare ACOs. Furthermore, the early rates of provider 
recommendations for appropriate CRC screening were very low (Klabunde et al., 2015).  
Patient behavior may be the primary driver of improving screening rates, as there 
has been association between patient behavior, the patient–provider relationship, and 
adherence to suggested clinical guidelines (Gudzune et al., 2014; Manteuffel et al., 2014). 
Several studies offered anecdotal patient interventions that increased patient success 
(Nathan et al., 2016; Singal et al., 2017; Slyne et al., 2017). Moreover, culturally 
competent approaches are important (Alsayid et al., 2019; Brittain & Murphy, 2015; 
Chen et al., 2016). Studies also documented perceived barriers as articulated by the 
provider and provider characteristics that influenced their decision making and ability to 
succeed (Mastrokostas et al., 2018; Wang et al., 2018). This included the ability to verify 
the patient’s CRC status or availability of specialists (Mastrokostas et al., 2018). For 
example, a provider recommendation is a primary influence on whether patients 
participate in CRC screenings (Bian et al., 2016; Bromley et al., 2015), which has been 
recommended more with health information technology to help alert a patient’s CRC risk 
(Kim et al., 2017; Mankaney et al., 2019). Additionally, it is important to implement 
systems that support patient engagement activities that influence behavior like 
motivational interviewing, goal setting, and shared decision making (Mishra et al., 2018). 
However, some providers have lacked the depth of understanding and practice to 
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implement these concepts in a meaningful way, and some provider experiences with 
difficult patients have led to feeling anxious, frustrated, and uncertain with little 
preparation for how to handle difficult patients (Shapiro et all, 2018). 
Ineffective communication and perceived provider uncertainty may also influence 
patient decision-making process (Beverly et al., 2016). Patients’ expectations of 
providers based on provider characteristics like age, race, and gender also influence their 
decisions (Alspach, 2018; Mast & Kadji, 2018). For example, uncertainty among female 
providers was seen as a form of truthfulness, whereas the trait generated mistrust for male 
providers (Mast & Kadji, 2018). Trust has also been demonstrated to be a contributing 
factor behind non-compliance of CRC screening for Hispanic patients (Hong et al., 
2018).  
Fear is another influencer of compliance for all patients, especially for African 
American patients (Basch et al., 2016; Bromley et al., 2015; Hall et al., 2016; Kiviniemi, 
Klasko-Foster et al., 2018; Mastrokostas et al., 2018). Fear presents in the form of fear of 
the findings from the procedure as well as fear of the procedure itself (Bromley et al., 
2015). Colonoscopy is the most popular form of CRC screening, which includes multiple 
steps like scheduling, bowel preparation, sedation and the procedure itself; some of which 
contain multiple levels of compliance (Powers & Keohane, 2018). Strategies such as 
enhanced written education, media campaigns, and videos improve compliance with 
bowel preparations (Andrealli et al., 2018; Cole et al., 2019; Essink-Bot et al., 2016). 
However, they have been less effective to improve patient health literacy and compliance 
for completing a colonoscopy (Clark et al., 2017; Enard et al., 2015; Mishra et al., 2018).  
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Further, studies suggest CRC compliance varies with the type of test offered, 
which could impact how providers achieve patient compliance with their 
recommendations (Alsayid et al., 2019; Basch et al., 2016; Bian et al., 2016; Brenner & 
Chen, 2017; Bromley et al., 2015; Chambers et al., 2016). Medicare recognizes four 
methods of CRC screening to achieve compliance with the ACO #19 measure: 
colonoscopy, DNA, stool testing, and fecal occult blood test (Prince et al., 2017).  
Key Variables and Alignment  
I explored the preventative quality performance measure (ACO #19) for CRC 
screening under MSSP ACO guidelines as the dependent variable across all three 
manuscripts. I explored how the independent variables of patient demographic 
characteristics race, age, gender, and insurance coverage predict performance. I also 
examined the relationship between practice size (i.e., size of attribution and number of 
primary care providers) and ACO #19. Manuscript 1 quantified overall performance of 
ACO #19 based on practice size followed by the influence of patient characteristics in 
Manuscript 2 and insurance coverage in Manuscript 3.  
Provider performance continues to be assessed by CMS (Preston et al., 2018). 
Most high performing ACOs have had positive collaboration with a hospital, established 
physicians focused on performance improvement, sophisticated information technology 
infrastructure, care coordinators, physician feedback, and an effective physician practice 
before joining the ACO (D’aunno et al., 2018). However, providers who had low quality 
metric measures before starting their ACO agreement had more room to improve and 
thus more to gain from their agreements (Green et al., 2015). Moreover, this range for 
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improvement narrowed in subsequent years once the provider’s performance level 
reached that of their peers. Assessments on the performance of the first ACOs also 
showed an increase in CRC screening for patients 65 years or older when compared to 
non-ACO patients or the start of the ACO model (Preston et al., 2018). Studies have also 
indicated that strategies to improve CRC screening rates include patient reminder 
programs (Gauci et al., 2018; Grimes et al., 2019), patient outreach programs (Singal et 
al., 2017), patient financial incentives (Mehta et al., 2019), embedded care coordinators 
and various patient decision aids (Reuland et al., 2017). 
Despite these strategies to increase engagement, significant disparities for 
screening rates have been found between White and non-White ACO members (Bromley 
et al., 2015). Additionally, the trend to improve quality measures has not been the case 
for ACOs in underserved communities or those with a higher number of minority patients 
(Bromley et al., 2015; Lewis et al., 2017). Yet provider payments continue to be the 
direct result of their ability to meet established benchmarks, including those for CRC 
screenings, which are ultimately based on patient behavior.  
Additionally, communication is a strategy often cited for improved patient 
outcomes (Ahmed & Bates, 2016; Alsayid et al., 2019; Beverly et al., 2016; Bientzle et 
al., 2015), but there are racial disparities in patient–physician communication (Foo et al., 
2017). Physician’s race has predicted the amount of time the physician spent talking with 
patients and the level of empathy they displayed. Research has also reported racial, 
socioeconomic, and gender bias among healthcare providers when making medical 
decisions (Williams, 2015), though some studies have found no relation to these 
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characteristics and provider decisions (Haider et al., 2015). Regardless, tailored 
communication based on patient characteristics can improve communication and patient 
engagement (Hagiwara et al., 2018), and the disconnect for cancer screening between the 
patient and provider has been compounded by the lack of provider continuity for minority 
patients (Arnold et al., 2017). 
Socioeconomic status is also a patient characteristic and determinant of CRC 
screening completion (Farrukh & Mayberry, 2019). Some ACO populations include 
underserved and vulnerable patients who are covered by Medicaid in addition to their 
Medicare coverage (Powers & Keohane, 2018). But studies have suggested that lower 
socioeconomic patients and Medicaid patients experienced bias when they pursued CRC 
screening (Davis et al., 2017). For example, Nymo et al. (2018) reported that patients 
with lower income experienced longer wait times when they scheduled CRC screening 
procedures, whereas patients with higher income were prioritized to enhance their patient 
experience and satisfaction. Though other studies have suggested Medicaid patients 
received more opportunities for CRC screening as care coordination improved for dual 
eligible patients (Craver et al., 2018), providers must be aware of both intentional and 
unintended bias when working with patients from different cultures and socioeconomic 
groups (Alspach, 2018). 
Conceptual Framework 
The socioecological model (SEM) guided my cross-sectional quantitative study in 
assessing data from the MSSP 2018 public use file (PUF). Under the SEM, provider 
performance is affected by factors that influence both their decision making and their 
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effectiveness to influence patient behavior (Rabarison et al., 2013). SEM posits five 
categorical levels that affect behavior change: the individual, interpersonal, 
organizational, community/environment, and society/policy levels (Lampard et al., 2013). 
Though the factors of the SEM are hierarchical, they are also integrated, and a change in 
one area could impact others (Coreil, 2009).  
The positivist ontology also guided my study. Positivism implies that there is a 
single truth (Burkholder et al., 2016). Medicare reports ACO #19 measure attainment 
through a PUF; thus, these results reflect a single truth of their performance. In 
Manuscript 1 I determined how provider size correlates to ACO #19 measure attainment. 
In Manuscript 2 I determined how patients’ race, age, and gender predicted providers’ 
ACO #19 measure attainment. In Manuscript 3 I determined how insurance coverage 
predicted how effective providers were at achieving ACO #19 measure attainment. The 
findings for each manuscript were the source of truth under the positivist ontology for my 
study. 
Overview of the Manuscripts 
My study provides a more comprehensive assessment of the physicians’ ability to 
influence patient behavior than quantitative data like those from CMS. The U.S. health 
care system is unsustainable with many health disparities across the population (Foo et 
al., 2017; Shrank et al., 2019). Thus, there is need to lower health care costs by 
influencing patient behavior protects vulnerable U.S. citizens at risk if the U.S. healthcare 
system collapses. A social justice perspective also applies to my study if findings can 
supplement previous research that shows differences in provider performance or 
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experiences correlating to race, gender, or socioeconomic status of their patients (Foo et 
al., 2017). The manuscripts were tied by the overarching theme of physicians’ influence 
on patient behavior. The manuscripts were framed as parallel projects where data 




Health care delivery and public health professionals form partnerships to reduce 
the burden of disease and are influenced by policies, healthcare costs, funding sources, 
and external demand (Cunningham et al., 2020). The MSSP ACO is an APM designed to 
curb cost and improve patient outcomes for colon cancer among other disease measures. 
Since CRC is a leading cause of death in the United States (Loyd, 2016), more research is 
needed to determine the impact of MSSP ACO providers on CRC screening. 
Research Question 
Based on the performance measures of the MSSP, what is the relationship 
between practice size and compliance with MSSP performance measure ACO #19? 
H0: There are no statistically significant differences in the compliance of MSSP 
performance measure ACO #19 based on practice size. 
Ha: There are statistically significant differences in the compliance of MSSP 
performance measure ACO #19 based on practice size. 
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Nature of the Study 
My cross-sectional quantitative study employed the MSSP PUF for secondary 
data analysis to examine the association between the independent variable practice size 
and the dependent variable of compliance with MSSP performance measure ACO #19. 
The 2019 MSSP PUF was used as a data source.  
Limitations, Challenges, and/or Barriers 
The MSSP PUF is a secondary data set and has a 1-year delay in reporting. A 
limitation to using the MSSP PUF file is that all quantitative data are restricted to the 
variables within the data set. For example, the Preventative Health Domain represents 
provider influence on patient behavior. These include public health initiatives presented 
by Healthy People 2020 like getting a flu shot during flu season, a plan to reduce 
unhealthy body weight, receiving help/information for tobacco use, getting a pneumonia 
vaccine, and screening for CRC (CMS, n.d.). My study examined ACO #19 or colon 
cancer screening, which is the most complex measure of behavior change captured by 
MSSP reporting (CMS, 2017). However, the MSSP PUF database provided an adequate 
sample size for successful compliance with ACO #19 to meet the statistical requirements 
of my study.  
Other Information 
My study assessed health professional’s influence on complex patient behavior. 
The MSSP ACO PUF contains physician performance against 32 measures across four 
domains (CMS, n.d.). The results were the official CMS findings and used to pay 
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provider incentives (Noble et al., 2014). Therefore, these measures were valid 
representations of physician performance. 
Manuscript 2 
Problem 
CRC is a leading cause of death in the United States, with significant disparities 
between population groups (Loyd, 2016). The MSSP ACO is an APM designed to curb 
cost, improve patient outcomes for colon cancer and other disease measures. But more 
research is needed to determine the impact of MSSP ACOs on CRC screening for 
different types of patients. 
Research Question 
Based on the performance measures of the MSSP, what is the relationship 
between the ACO population's demographics race, age, and gender and compliance with 
MSSP performance measure ACO #19? 
H0: There are no statistically significant differences in compliance with MSSP 
performance measure ACO #19 based on the ACO population's demographics, race, age, 
and gender. 
Ha: There are statistically significant differences in compliance with MSSP 
performance measure ACO #19 based on the ACO population's demographics, race, age, 
and gender. 
Nature of the Study 
The nature of Manuscript 2 was a cross-sectional quantitative study and employed 
the MSSP PUF for secondary data analysis to examine the association between the 
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independent variables race, age, and gender and the dependent variable of compliance 
with MSSP performance measure ACO #19. Again, the 2019 MSSP PUF was the 
primary data source.  
Limitations, Challenges, and/or Barriers 
The MSSP PUF is a secondary data set and has a 1-year delay in reporting. A 
limitation to using the MSSP PUF file is that all quantitative data are restricted to the 
variables within the data set. For example, the Preventative Health Domain represents 
provider influence on patient behavior. These include public health initiatives presented 
by Healthy People 2020 like getting a flu shot during flu season, a plan to reduce 
unhealthy body weight, receiving help/information for tobacco use, getting a pneumonia 
vaccine, and screening for CRC (CMS, n.d.). My study examined ACO #19 or colon 
cancer screening, which is the most complex measure of behavior change captured by 
MSSP reporting (CMS, 2017). However, the MSSP PUF database provided an adequate 
sample size for successful compliance with ACO #19 to meet the statistical requirements 
of my study. 
Manuscript 3 
Problem 
CRC is a leading cause of death in the United States, with significant disparities 
between population groups (Loyd, 2016). The MSSP ACO is an APM designed to curb 
cost, improve patient outcomes for colon cancer and other quality measures. Studies 
suggest bias and disparities for patients based on sociodemographic status (Foo et al., 
2017). Furthermore, research has demonstrated disparities in CRC screening based on 
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insurance type (Kiviniemi et al., 2018). Thus, ore research is needed to determine the 
impact of MSSP ACO on CRC screening for patients with different types of insurance. 
Research Question 
Based on the performance measures of the MSSP, what is the relationship 
between insurance coverage and compliance with MSSP performance measure ACO 
#19? 
H0: There are no statistically significant differences in compliance with MSSP 
performance measure ACO #19 based on insurance coverage. 
Ha: There are statistically significant differences in compliance with MSSP 
performance measure ACO #19 based on insurance coverage. 
Nature of the Study 
The nature of Manuscript 3 was a cross-sectional quantitative study and employed 
the MSSP PUF for secondary data analysis to examine the association between the 
independent variable insurance coverage and the dependent variable of compliance with 
MSSP performance measure ACO #19. Again, the primary source of data was the 2019 
MSSP PUF. 
Limitations, Challenges, and/or Barriers 
The MSSP PUF is a secondary data set and has a 1-year delay in reporting. A 
limitation to using the MSSP PUF file is that all quantitative data are restricted to the 
variables within the data set. For example, the Preventative Health Domain represents 
provider influence on patient behavior. These include public health initiatives presented 
by Healthy People 2020 like getting a flu shot during flu season, a plan to reduce 
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unhealthy body weight, receiving help/information for tobacco use, getting a pneumonia 
vaccine, and screening for CRC (CMS, n.d.). My study examined ACO #19 or colon 
cancer screening, which is the most complex measure of behavior change captured by 
MSSP reporting (CMS, 2017). However, the MSSP PUF database provided an adequate 
sample size for successful compliance with ACO #19 to meet the statistical requirements 
of my study. 
Significance 
Each manuscript provided data that may improve the strategies public health and 
health care delivery professionals use to reduce the burden of CRC. I addressed a gap in 
research in Manuscript 1 to show how ACOs with more patients were more compliant 
with CRC screening recommendations, though results indicated that more non-White 
patients were less compliant with screenings and the number of providers in an ACO did 
not influence compliance with the measure. In Manuscript 2, I expanded on current 
literature on disparities in CRC screening based on race, age, and gender. I found that 
ACOs with more Black patients were less compliant with ACO #19. I also demonstrated 
that ACOs with patients between the age of 65–85 more likely meet CRC 
recommendations. Lastly, I addressed a gap in research in manuscript 3 to show ACO 
#19 performance decreases as the number of Medicaid patients in the population 
increases.   
My research can help decrease disparities for CRC screening and incidence of 
CRC among vulnerable populations. Furthermore, the data may help public health 
professionals, community advocates, and healthcare providers drive behavior adoption 
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for their community members. Lastly, my study provides a foundation for population 
health initiatives beyond CRC related illness.  
Policy 
Alternative practice models incorporate value-based care methodologies that 
move health care away from a costly volume-driven fee-for-service structure toward 
quality incentivized population health management frameworks, many of which hinge on 
partnerships between primary care physicians and public health organizations (Nywelde 
et al., 2015). Manuscript 1 applies to policies that govern the minimum number of 
patients in ACOs that might influence CRC screening rates for elderly patients. 
Furthermore, the results can influence policy related to provider patient ratios. 
Manuscript 2 applies to policies that support health and wellness initiatives in 
communities of color and patients aged 65 year and older. Manuscript 3 can influence 
policy related to insurance coverage particularly for Medicaid and Medicare patients, 
applying toward additional policies for lower socioeconomic populations as to the 
eligibility for these services and the scope of benefits they receive. 
Overall, my study will influence policy by outlining the success, shortcomings, 
and possible rationale for health outcomes. This could provide policymakers a unique 
perspective to maintain or improve the MSSP ACO program or other partnership 





Each manuscript promotes positive social change by providing meaningful data to 
the public health organization and health care provider partnerships engaged in 
transforming healthcare from a transactional delivery system to an evidence-based system 
of value (Berenson et al., 2016). Manuscript 1 may improve public health and healthcare 
professionals’ ability to influence the behaviors and health outcomes of the community 
members they serve and provide an evidence-based approach to determining the structure 
or model for programs designed to improve health outcomes. Manuscript 2 can help 
decrease the prevalence and disparities of CRC and by doing so reduce the economic and 
quality of life burden for individuals and communities suffering from the disease. 
Moreover, Manuscripts 2 and 3 may help to reduce disparities for CRC screening and 
incidence of CRC among vulnerable populations.  
Overall, my study provides a foundation for population health initiatives beyond 
CRC related illness, thus improving the well-being of communities and increase public 
health emergency preparedness. Therefore, my study can improve public health and 
healthcare professionals’ ability to influence the behaviors and health outcomes of the 
community members they serve. My findings can guide both public health and healthcare 
provider leaders on ways to train professionals better, reduce frustration, improve 
success, and achieve higher levels of satisfaction in their work both in routine 




Each manuscript explores Medicare’s MSSP ACOs as one of the interventions 
initiated by CMS to promote collaboration, better health outcomes, and lower costs of 
care for patients 65 years or older (Noble et al., 2014). One component of ACOs includes 
preventative care (Noble et al., 2014). Public health professional and healthcare providers 
have mutual interest to increase appropriate CRC screening rates to reduce the incidence, 
economic burden, and mortality from CRC (Bachman et al., 2018; Bachrach et al., 2016). 
But studies suggest disparities among the population for age, sex, and ethnicity (Bachman 
et al., 2018). Studies also show an ongoing variance of care delivered to people with 
different levels and type of insurance coverage (Kiviniemi et al., 2018; Manteuffel et al., 
2014). Thus, I assessed the effectiveness of meeting CRC screening guidelines based on 
provider size, patient characteristics variables and patient insurance type for ACO #19 





Part 2: Manuscripts 
The Relationship Between Advanced Payment Model Providers and Patient 
Behavior: Practice Size and Provider Influence on Patient Behavior 
 
 




Objective: This study assesses the preventative quality performance measure (ACO #19) 
for colon cancer screening under Medicare Shared Savings Plan ACO guidelines. I 
quantified the overall performance of ACO #19 based on provider practice size.  
 
Methods: A cross-sectional quantitative study was conducted for organizations who 
participate as a Medicare Shared Savings Plan Accountable Care Organization. The 
research included secondary data analysis of the 2019 Medicare Shared Savings Plan 




Outlet for Manuscript 
The American Journal of Public Health (AJPH) is the intended journal for this 
manuscript (https://ajph.aphapublications.org/). The initial submission requires a title 
page with the manuscript title, author name and affiliations, and full abstract and the 
manuscript with author and university information removed. In addition, the manuscript 
should contain the following elements: 
a. Title and abstract 
b. page numbers 
c. numbered lines (in Word, > Page Setup > Line Numbers > Continuous) 
throughout the text of the manuscript; 
d. 1.5 or double spacing with a font size of 12 
e. tables and figures embedded at the end of the manuscript, OR uploaded as 
separate files 
Submission also requires a cover letter with concise text (maximum 150 words) that 
provides a description of what the paper adds to the knowledge on the topic, especially in 
respect to material previously published in the journal and elsewhere; includes the public 
health importance of the paper; and highlights the main message of the paper in one 
sentence. With the exception of history essays, all AJPH articles follow the AMA Manual 





Public health efforts include vaccination and screening initiatives to reduce the burden of 
disease. This study focused on colorectal cancer (CRC) screening behaviors of 
accountable care organization (ACO) patients of different population sizes. It addressed 
performance among organizations based on the number of primary care providers in the 
ACO. This study used the socioecological model and a cross-sectional quantitative design 
to assess data from the Medicare Shared Savings Plan public use file 2019 to expand on 
current literature that determined patient behavior was the primary driver to improve 
healthcare quality and reduce costs. ACOs with more patients generally had better CRC 
screening compliance. However, the results showed that ACOs with more non-White 
patients were less successful. Results also indicated that participating in an ACO may 
mediate the constraints of smaller provider practices to improve patient care, though the 
results found that lesser numbers of primary care providers in an ACO did not negatively 
influence performance. The implications for positive social change include data to reduce 
disparities for CRC screening and incidence of CRC among vulnerable populations and 
provide a foundation for population health initiatives and policies beyond CRC related 
illness, which can improve the well-being of communities and increase public health 






Healthcare costs in the United States are rising at an unsustainable rate and 
include significant disparities in health outcomes that have been attributed to social 
determinants of health (Foo et al., 2017; Noble et al., 2014). Physicians and public health 
professionals lead much of the effort to manage this public health crisis (Ingram et al., 
2015). As a result, public health agencies and clinical health organizations have formed 
partnerships in several communities to form new public healthcare delivery models 
(Noble et al., 2014). These partnerships were designed to improve health by influencing 
individual behavior and addressing social determinants of health (Bachrach et al., 2016). 
For example, the Institute of Healthcare Improvement’s Quadruple Aim outlined a 
framework to improve health outcomes, lower healthcare costs, improve patient 
experience, and improve clinician satisfaction (Wagner et al., 2018). This contributed to 
the development of experimental alternative payment delivery models (APMs) to achieve 
components of the Quadruple Aim, but these new designs had varying degrees of success 
(Noble et al., 2014). Studies have shown that population engagement was essential to 
guide community members toward behaviors that lead to healthier outcomes, which 
could reduce the overall cost of care (Grand et al., 2014); however, there was little 
evidence of which strategies were most successful at influencing the population’s 
behavior.  
Problem 
Physicians have indicated that patient behavior is the key to improve health 
quality and outcomes, yet many have found it difficult to influence individual behavior 
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(Hibbard et al., 2015). Moreover, researchers have found disparities in patient 
compliance with health behavior recommendations (Kiviniemi et al., 2018; Manteuffel et 
al., 2014) linked to patient characteristics and provider variables like the size of provider 
practices (Kiviniemi et al., 2018; Manteuffel et al., 2014). Data on the patient experience 
are captured through performance reporting by the Centers for Medicare and Medicaid 
Services (CMS, n.d.), and patient perspectives toward patient engagement have been well 
documented in the literature (Rowland et al., 2017). However, provider experiences, 
perceptions, success, and strategies to engage community members attributed to their 
APMs are not represented in detail in previous research (Andrealli et al., 2018; 
Bekmuratova et al., 2019; Berenson et al., 2016; Chen et al., 2016). Thus, there is an 
inability to replicate the best practices for population engagement that improve 
participant experiences, job satisfaction, health outcomes, and lower costs. I addressed 
this gap in research by focusing on the relationship of practice size and providers’ 
influence on APM patient behavior. I explored the preventative quality performance 
measure for colon cancer screening ACO #19 for the Medicare Shared Savings Plan 
(MSSP) accountable care organization (ACO) guidelines.  
Significance of the Study 
APMs introduced patient engagement initiatives to lower healthcare costs in the 
United States with different levels of success (Noble et al., 2014). Extensive quantitative 
data on APM quality are captured by CMS performance reports (CMS, n.d.). The 
literature, however, has not shown evidence on why physicians were successful at 
influencing patient behavior. For example, Smiddy et al. (2015) showed that financial 
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incentives increased the number of focus groups in the United Kingdom but found little 
impact on the quality of care delivered. In the current study, I explored provider 
experiences with managing patient populations of different sizes and ethnicities to 
explain to what degree they affect patient behavior compared to the measures that 
determine their payments and further explain the impact of provider collaboration within 
advanced payment models on their outcomes. My study showed that ACOs with larger 
patient populations were more compliant with CRC screening recommendations, and 
ACOs with more non-White patients were less compliant with screenings. Further, the 
number of providers in an ACO did not influence compliance with the measure. 
Relevant Contribution to the Body of Knowledge  
This manuscript is the first of three manuscripts to a cross-sectional quantitative 
study to explore the preventative quality performance for colon cancer screening under 
MSSP ACO guidelines. My broader study explores how patient demographic 
characteristics race, age, gender, and insurance coverage predict performance. The 
purpose of my study was to assess the relationship between practice size and provider 
effectiveness at influencing patient behavior as measured by the compliance of MSSP 
performance measure ACO #19. This manuscript fills a gap in research by focusing on 
provider practice characteristics. My cross-sectional study provides a more 
comprehensive assessment of physician influence on patient behavior than studies like 




The socioecological model (SEM) guided my cross-sectional quantitative study in 
assessing data from the MSSP public use file (PUF). Under the SEM, provider 
performance is affected by factors that influence both their decision making and their 
effectiveness to change patient behavior (Rabarison et al., 2013). SEM posits five 
categorical levels which affect behavior change: the individual, interpersonal, 
organizational, community/environment, and society/policy levels (Lampard et al., 2013). 
Though the factors of the SEM are hierarchical, they are also integrated, and a change in 
one area could impact others (Coreil, 2009).  
The positivist ontology also guided my study. Positivism implies that there is a 
single truth (Burkholder et al., 2016). Medicare reports ACO #19 measure attainment 
through a PUF; thus, these results reflect a single truth of their performance. I showed 
how the number of providers in an ACO and the size of the patient population correlate to 
their ACO #19 measure attainment. These findings are the source of truth under the 
positivist ontology for my study. Additionally, the definition of “provider success” is 
precise and supports a quantitative ontology of positivism where there is one true reality 
(Burkholder et al., 2016). Positivism guided my cross-sectional quantitative study to 
answer the question “How effective were providers at influencing patient behavior based 
on the performance measure ACO #19 of the Medicaid Shared Savings Plan?” I analyzed 
archival data from the CMS to support the positivist approach to my research question 
(Burkholder et al., 2016).  
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My study is influenced by multiple contexts. The personal contexts for my study 
include my knowledge and experience with advance payment models and patient 
engagement. The social contexts include CMS guidelines, the fluidity of US healthcare 
policy, political climate, geographic locations, and local healthcare delivery priorities. 
Lastly, interpersonal contexts include Walden University dissertation committee 
representatives. 
Background 
The first ACOs were created to reduce preventable health problems amid cost 
constraints have varied in United States (Noble et al., 2014). Hibbard et al. (2015) 
documented that compensation from similar models used in other countries influenced 
physician opinions on the importance of patient behavior. They further provided evidence 
that patient behavior was the primary driver of improving quality (Hibbard et al., 2015). 
Other studies showed that improvements in patient engagement lead to better health 
outcomes (Simmons et al., 2014; Grand et al., 2014)), and that both independent 
healthcare professionals and healthcare organizations committed significant investments 
to improve outcomes, lower costs and improve patient experiences (Nwelde et al., 2015).  
Physicians in the United States agreed that patient behavior was the key 
determinant to improve quality and outcomes, yet, many found frustration when trying to 
influence individual behavior (Hibbard et al., 2015). While many providers perceived 
their role in the community and within population health as “medicine-based”; a growing 
emphasis on preventative care and the diverse characteristics of their patient attribution 
fostered better collaboration between healthcare providers and traditional public health 
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organizations (Ingram et al., 2015). This was particularly true for mutual objectives such 
as cancer prevention (Basch et al., 2016).  
Research showed that differences in the structures of provider practices 
influenced their capacities to provide care and influence patient behavior (Casalino & 
Chenven, 2017; Casalino et al., 2013; Kim et al., 2017; Pineault et al., 2016). These 
included financial stability, training, staff, and other key resources like health information 
technology (Casalino & Chenven, 2017; Casalino et al., 2013; Kim et al., 2017). 
However, researchers have suggested that some providers believed collaborative 
partnerships might mediate resource constraints tied to their practice size and geographic 
designation (Kim et al., 2017). Other evidence showed that the collective patient 
population was based partly on their practice size and was a key determinant of their 
success with CMS quality measurements (Greene et al., 2015). 
ACOs were designed to shift the focus of healthcare services from a traditional 
fee for service structure to a value-based care model tied to better health outcomes (Noble 
et al., 2014). Nyweide et al. (2015) proved the initial performance under the Medicare 
ACO model lowered costs when compared to traditional Medicare fee-for-service 
beneficiaries. The CMS measures ACO providers across four domains, which include 
care coordination, patient safety, patient experience, and preventative health (Mod et al., 
2018). Providers are paid more for achieving multiple quality metrics outlined in their 
ACO contracts and for the providing care at a lower cost. as well as (Noble et al., 2014). 
Studies showed that many healthcare providers including those in underserved areas saw 
ACOs as a means to provide greater quality while improving population health 
29 
 
(Bekmuratova et al., 2019; Berenson et al., 2016). Furthermore, some organizations 
perceived the goal to improve patient care, simply outweighed any financial rewards they 
may receive (Phipps-Taylor & Shortell, 2016). Conversely, other evidence showed that 
providers avoided ACO membership as they did not have the infrastructures or 
collaborative relationships in place to succeed (Bekmuratova et al.).  
Colorectal cancer (CRC) is a leading cause of death in the United States (Lloyd, 
2016). The Centers for Disease Control and Prevention estimated over 40,000 deaths 
attributed to colon cancer in 2016 (Bachman et al., 2018). CRC screening is a key public 
health focus and measurement of ACOs. The risk of CRC mortality can be reduced with 
early detection (Lloyd, 2016). Focused efforts to increase CRC screening led to an 
overall reduction of CRC related deaths in the last decade; yet, several disparities 
continue to exist across, socioeconomic and racial/ethnic boundaries (Bromley, May, 
Federer, Spiegel, & Van Oijen, 2015). Klabunde et al. (2015) reported that almost 25% of 
adults between 76 and 84 did not meet the U.S. Preventative Services Task Force 
recommendations for CRC screening before the advent of Medicare ACOs. Furthermore, 
the incidence of provider recommendations for appropriate CRC screening was very low 
(Klabunde et al., 2015). This problem was further compounded with racial disparities for 
non-White patients who were less likely to complete screening and had an increased 
prevalence of adverse health outcomes as a result (Klabunde et al.).  
A growing body of evidence also documented disproportionate racial and 
socioeconomic disparities and highlighted the diverse needs to motivate patients toward 
compliance (Ashktorab et al., 2017; Bromley et al., 2015; Burnett-Hartman et al., 2016; 
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Chablani et al., 2017). Several studies offered anecdotal patient interventions which 
increased patient success (Nathan et al., 2016; Singal et al., 2017; Slyne et al., 2017). 
Studies which focused on patient experience suggested culturally competent approaches 
based on different patient characteristics (Alsayid et al., 2019; Brittain & Murphy, 2015; 
Chen et al., 2016). Research also documented provider perceptions of barriers and 
provider characteristics that influenced their decision making and success (Mastrokostas 
et al., 2018; Wang et al., 2018). These included the basic ability to verify their patients’ 
correct CRC status and the clinician’s ability to confer with specialists (Mastrokostas et 
al., 2018). 
For example, a provider recommendation was a primary influence on whether 
patients of all demographic groups participated in CRC screenings (Bian et al., 2016; 
Bromley et al., 2015). Some studies showed that health information technologies that 
shared patient information, alerted providers to the patient’s CRC risk and screening 
status nudged providers to provide CRC screening recommendations (Kim et al., 2017b; 
Mankaney et al., 2019). Additionally, other studies reiterated the importance of Patient 
Behavior on quality performance and the need to implement systems to support patient 
engagement activities that influence behavior (Mishra et al., 2018). These included the 
concepts of, motivational interviewing, goal setting, and shared decision making (Mishra 
et al., 2018). However, a study conducted by Mishra and colleagues (2018) showed that 
while providers were aware of these concepts, they lacked the depth of understanding and 
practice to implement them in a meaningful way. Shapiro et al. (2018) further described 
provider experiences with tough to manage patients in which providers described 
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themselves as anxious, frustrated, and uncertain with little preparation for how to handle 
difficult patients. 
Ineffective communication and perceived provider uncertainty may influence 
patient decision-making process (Beverly et al., 2016). This can also be confounded by 
patients' expectations based on the provider’s characteristics such as age, race, gender and 
experience (Alspach, 2018; Mast & Kadji, 2018).Fear was another influencer of 
compliance for all patients, but particularly among non-White patients (Basch et al., 
2016; Bromley et al., 2015; Hall et al., 2016; Kiviniemi, Klasko-Foster et al., 2018; 
Mastrokostas et al., 2018). Fear presented in the form of fear of the findings from the 
procedure as well as fear of the procedure itself (Bromley et al., 2015).  
Colonoscopy is the most popular form of CRC screening, and includes multiple 
steps like scheduling, bowel preparation, sedation, and the procedure itself; some of 
which contain multiple levels of compliance (Powers et al., 2018). For example, 
strategies such as enhanced written education, media campaigns, and videos improve 
compliance the bowel preparation step of colonoscopies (Andrealli et al., 2018; Cole et 
al., 2019; Essink-Bot et al., 2016). However, they were demonstrated as less effective to 
improve patient health literacy and compliance for completing the colonoscopy procedure 
(Clark et al., 2017; Enard et al., 2015; Mishra et al., 2018).  
Medicare recognizes four methods of colonoscopy screening to demonstrate 
compliance with the ACO #19 measure (Prince et al., 2017). These include colonoscopy, 
DNA, stool testing, and fecal occult blood test. Studies suggest CRC compliance varies 
with the type of test offered, Thus, could impact the CRC screening recommendations 
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that providers make to their patients (Alsayid et al., 2019; Basch et al., 2016; Bian et al., 
2016; Brenner & Chen, 2017; Bromley et al., 2015; Chambers et al., 2016). 
My study fills a gap in research by focusing on provider practice characteristics 
and the abilities of providers to influence the behavior of ACO patients to achieve 
compliance with CRC screening recommendations. 
Research Questions and Design 
The nature of the manuscript is a cross-sectional quantitative study for the 
following research question:  
Based on the performance measures of the MSSP, what is the relationship 
between practice size and compliance with MSSP performance measure ACO #19? 
H0: There are no statistically significant differences in compliance with MSSP 
performance measure ACO #19 based on practice size. 
Ha: There are statistically significant differences in compliance with MSSP 
performance measure ACO #19 based on practice size. 
Cross-sectional quantitative studies are descriptive research to describe 
community characteristics at a single point in time. I analyzed data from the MSSP PUF 
from 2019. I assessed the relationship of dependent variable ACO performance for 
measure ACO #19 and the independent variable practice size. My research design 
required a way of to measure patient behavior. CMS ACO #19 is a cumulative measure 
based on the number of people that participated in CRC screening. Therefore, I assumed 





ACO #19: Percentage of adults between 50–75 years of age who had appropriate 
screening for CRC for ACO quality reporting (CMS, 2017). 
Alternative payment delivery models (APMs): Several experimental 
advance/APMs have been created with varying success to introduce new patient 
engagement initiatives to combat the United States skyrocketing healthcare costs (Noble 
et al., 2014). 
Attribution: The patients assigned to the health care provider for which they are 
being measured (Noble et al., 2014). 
Patient engagement: Studies show that improvements in patient engagement lead 
to better health outcomes (Simmons et al., 2014). 
Practice size: The number of patients and the number of primary care physicians 
in an ACO. 
Bias and Limitations 
I analyzed archived data from the CMS. Therefore, the quality of this quantitative 
data source was beyond my control as the researcher and contingent on the data 
collection process for MSSP reporting (Burkholder et al., 2016). CMS (2017) allows 
providers to review and dispute published performance data, followed by a final CMS 
ruling. I used the final report issued by CMS, which included corrections to improve data 
quality. I could not control confounding variables that may influence provider–patient 
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attribution (Noble et al., 2014). These included patient comorbidities that can affect 
patients abilities to comply with healthcare treatment plans (DeJean et al., 2013).   
Scope and Delimitations 
The MSSP ACO PUF details physician performance against 32 measures across 
four domains (CMS, n.d.). The results are the official CMS findings and used to pay 
provider incentives (Noble et al., 2014). Therefore, these measures are valid 
representations of physician performance. The scope of my study was to evaluate 
physicians’ performance against the CMS measurement for colon cancer screening ACO 
#19.  
I limited my target population to the subset of organizations that had previous 
experience with MSSP ACOs and those who reported data for the 2019 MSSP reporting 
year. Excluding first-year MSSP participants improved credibility by ensuring that 
providers in the sample had a baseline measurement that reflected their performance 
better (Noble et al., 2016). Disparities in provider–patient interactions may be influenced 
by the factors race and patient insurance coverage (Foo et al., 2017). Therefore, a third 
delimitation limited the participant sample to those with a patient base with at least 10% 
non-White and accept both Medicaid and Medicare patients (CMS, 2017). Succesful 
attainment of ACO #19 was determined by a score of at least 30% (CMS, 2017). I 
differentiated well-performing providers from poor performing using this recognized 




Positivism guided the cross-sectional quantitative study to answer the question, 
“How effective are providers at influencing patient behavior based on the performance 
measure ACO #19 of the Medicaid Shared Savings Plan?”  Archival data analysis from 
the CMS 2019 MSSP PUF supported the positivist approach to my research question. I 
used the quality performance data for healthcare providers reported in the PUF to 
determine their effectiveness at influencing patient behavior as it correlated to their 
practice size. 
Instrumentation 
Archival data from the MSSP PUF for 2019 was used for the data collection 
process. The MSSP ACO PUF was derived from a combination of provider claims and 
survey data. The PUF files are available for performance years 2013-2019. The PUF file 
included hundreds of variables, descriptions and performance measure outcomes. These 
included measures for six behavior related preventative measures. Performance measures 
were captured as a percent of the total population where a higher score means higher 
performance for that measure. 
Provider incentives for MSSP ACOs were based on quantitative analysis of their 
performance against established benchmarks (Noble et al., 2014). As such the current 
reporting for the effectiveness of APMs is dichotomous as the providers did or did not 
meet their measurement objectives (CMS, n.d.). This clear determination of provider 
success supports a quantitative ontology of positivism in which there is one true reality 
(Burkholder et al., 2016). Furthermore, quantitative analysis of provider performance 
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using MSSP public use data is an accepted practice among the healthcare community 
(Noble et al., 2016).  
Participants 
I limited the evaluation of provider performance  to organizations in the United 
States who had previous ACO experience prior to 2019 and who reported data for the 
2019 MSSP reporting year. Previous studies showed that providers treated patients 
differently according to sociodemographic characteristics (Foo et al., 2017; Manteuffel et 
al., 2014). Therefore, I restricted participants  to ACOs with a patient base of at least 10% 
non-White and who accepted both Medicaid and Medicare patients. Furthermore, CMS 
set a minimum standard of 30% achievement to comply with MSSP guidelines. 
Therefore, participant selection was based on provider performance compared to the  
30% benchmark. 
Data Sources 
Archival data was reviewed from the MSSP PUF for 2019. I used data for new 
and returning ACO participants from the 2019 MSSP PUF. I described the extent that 
ACOs were successful with measure ACO #19. I uploaded the entire MSSP PUF 
database into SPSS v25 for review, analysis and statistical testing.  
Quantitative Collection and Analysis 
I assessed how effective ACOs were at changing patient behavior. I described the 
extent that ACOs were successful at achieving colon cancer screening for measure ACO 
#19. I uploaded the entire 2019 MSSP PUF database into SPSS v25 for review, analysis 
and statistical testing. I retained the native MSSP PUF document, which was uploaded 
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multiple times with all statistical tests replicated to ensure integrity and reliability. I used 
Pearson Correlation and linear regression to determine if there was a significant 
relationship between ACO practice size and performance. The level of significance was 
set to 0.05.  
Results 
Research question: Based on the performance measures of the MSSP, what is the 
relationship between practice size and compliance with MSSP performance measure 
ACO #19? 
H0: There are no statistically significant differences in the compliance of MSSP 
performance measure ACO #19 based on practice size. 
Ha: There are statistically significant differences in the compliance of MSSP 
performance measure ACO #19 based on practice size. 
Execution 
I assessed archival data from the MSSP PUF (CMS, n.d.) for 2019 for 470 ACOs. 
I calculated an additional variable to reflect the percentage of the total population by race, 
age, gender, and Medicaid status in Microsoft Excel. The modified file was then entered 
into SPSS version 25 to organize, code, and screen data. Data for ACO #19 score and 
practice size were recoded to ordinal categorical data. Values were calculated including 
frequency counts and percentages with SPSS. Descriptive data analysis was performed 
for frequencies for all ACOs.  
The final sample size was narrowed to 140 ACOs based on the inclusion and 
exclusion criteria for the study. These included previous experience in the MSSP 
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program and an ACO #19 score of 30 or more, an attribution that was at least 10% non-
White. I performed statistical assumption tests for normal distribution, homoscedasticity, 
and linearity between dependent and independent variables before research question 
analysis. Table 1 summarizes the dependent, independent variables, and statistical 
analyses used to evaluate the research question. 
Table 1 
 
Variables and Statistical Tests Used to Evaluate Research Questions 
Research Question 
Dependent 
Variable Independent Variable Analysis 
What is the relationship 
between practice size and 
compliance with MSSP 
performance measure ACO 
#19? 
ACO #19 Score Practice Size-Providers Pearson Correlation Linear Regression 
    
What is the relationship 
between practice size and 
compliance with MSSP 
performance measure ACO 
#19? 
ACO #19 Score Practice Size-Attribution Pearson Correlation Linear Regression 
Note. ACO = accountable care organization 
Descriptive Statistics for all ACOs 
Descriptive analysis for all (n = 470) ACOs and the target sample (n = 140) were 
conducted for ACO #19 performance. Frequencies were reviewed for practice size and 
characteristics of ACO attributions for age, race, gender, and insurance. Table 2 shows 
the ACO #19 performance with most organizations achieving between 50 and 90%. 
Performance for the target population aligned with the larger base with most 
organizations (n = 85) achieving between 70–89% followed by those between 50–69% (n 





ACO #19 Performance Range and Frequency 
 All ACOs   Target ACOs 
ACO #19 Score Frequency Percent   Frequency Percent  
0-29 4 0.9     
30-49 13 2.8   4 2.9 
50-69 157 33.4   47 33.6 
70-89 287 61.1   85 60.7 
90 to 100 9 1.9   4 2.9 
Total 470 100.0   140 100.0 
Note. ACO = accountable care organization 
Practice size as measured by primary care physicians ranged from 20 to 2,299. 
Table 3 shows that most ACOs had less than 200 primary care providers with the 
majority falling between 50–99 at roughly 22%. 
Table 3 
 
Range and Frequency of Primary Care Providers in ACOs 
 All ACOs Target ACOs 
 Primary Care Providers Frequency Percent Frequency Percent  
0-49 72 15.3 15 10.7 
50-99 101 21.5 32 22.9 
100-149 74 15.7 18 12.9 
150-199 41 8.7 11 7.9 
200-249 30 6.4 9 6.4 
250-299 25 5.3 9 6.4 
300-349 15 3.2 5 3.6 
350-399 16 3.4 6 4.3 
400-499 30 6.4 8 5.7 
500-599 16 3.4 7 5.0 
600 or more 50 10.6 20 14.3 
Total 470 100.0 140 100.0 
Note. ACO = accountable care organization 
Table 4 shows the practice size characteristics based on patient attribution for all 
ACOs. ACOs that did not report a score for ACO #19 (n = 4) were removed. Of the 
remaining (n = 466) there was a total of 9,918,470 patients enrolled in the ACOs of 
which 4,275,182 (43%) were male and 5,643,285 (57%) female. Eighty-six percent of the 
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population was white and 14% non-White. Ages ranged from 0-64 (14%), 65-74 (46%), 
75-84 (28%) and 85 or older (12%). Beneficiaries with Medicaid totaled 606,989. The 
patient attribution for all ACOs ranged from 2,193 to 239,924 patients.  
Table 4 
 
Range and Percentage of Attributions Across All ACOs 
  Minimum Maximum Sum Percent 
Total Patients 2,193 239,924 9,918,470   
Female 1,240 133,423 5,643,285 57% 
Male 953 106,501 4,275,182 43% 
Medicaid Patients 67 17,981 606,989 6% 
Non-Medicaid Patients 1,346 181,135 7,917,736 80% 
Total Age 0_64 262 41,238 1,369,626 14% 
Total Age 65_74 817 109,019 4,607,276 46% 
Total Age 75_84 619 64,190 2,799,157 28% 
Total Age 85Plus 186 25,477 1,142,411 12% 
White 479 219,069 8,519,870 86% 
Non-White 97 24,215 1,398,600 14% 
 
The attribution of most ACOs in the target population was under 40,000 patients. 
Table five shows that over half of the ACOs carried an attribution of between 10,000 and 
39,999 followed by a range of 2,193 to 9,999 (27%).   
Table 5 
 
Range and Percentage of Attribution 
Attribution Range Frequency Percent  
0-9,999 38 27.1 
10,000-39,999 77 55.0 
40,000-79,999 19 13.6 
80,000 or more 6 4.3 
Total 140 100.0 
 
Tests of Assumptions 
I conducted assumption tests of the dependent variable ACO #19. The data were 
normally distributed and follow a normal distribution curve. The skewness and kurtosis 
tests for normal distribution should fall between the rage of ± 2 and ±7 respectfully. The 
41 
 
ACO #19 score data for skewness was -.287 and kurtosis was -.692. The Kolmogorov-
Smirnov test for normality was insignificant at p>.05. Figure one shows the normal Q-Q 
plot of the data.  
Figure 1 
 
Normal Q-Q Plot for ACO #19 Performance 
 
 
Inferential Statistics Manuscript 1 
Previous studies define practice size as the total number of patients or the total 
number of primary care physicians. I found practice size as defined by the total number 
of primary care physicians in the ACO did not significantly influence ACO #19 
performance. However, the results showed that practice size as defined by the total 
number of patients had a statistically significant influence on ACO #19 performance. 
Thus, the null hypothesis that practice size does not have a significant influence on ACO 
#19 performance was rejected. I used bivariate correlation to determine relationship 
between the dependent variable ACO #19 Performance and independent variables for 
practice size. There was not a significant correlation between ACO #19 performance and 
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the number of primary care providers. However, there was a statistically significant 
Pearson Correlation of .214 between ACO #19 and the number of patients with p = .011. 




ACO Practice Size Attribution 
 
Note. ACO = accountable care organization 
Furthermore, analysis showed the number of non-White patients was not 
significant but the percentage of the total population size that was non-White had a 























1 .214* 0.087 0.014 -.416** 
P value 
 
0.011 0.309 0.871 0.000 
N 140 140 140 140 140 
Note. ACO = accountable care organization. *. Correlation is significant at the 0.05 level 
(2-tailed). **. Correlation is significant at the 0.01 level (2-tailed). 
Linear Regression 
I used linear regression to further analyze the correlations between ACO #19 
Performance and the independent variables of total patients and percent of population that 
was non-White. The influence of total patients on performance was statistically 
significant (F(1,138) = 6,596, p<.05).The total number of patients attributed to the 
variance in positive correlation by 4.6% with an R2 value of .046 and adjusted R2 of .039. 
ACO #19 performance increased as population size increased with a coefficient of B = 
8.9.  
The relationship between the percent of non-White patients of the total practice 
size and ACO #19 performance was statistically significant (F(1,138) = 28.8, p<.05).The 
percentage of non-White patients of the total population based attributed to the variance 
in negative correlation by 17.3% with an R2 of .173 and an adjusted  R2 of .167. ACO #19 






My research correlates with previous research around physician influence on 
paitent behavior and patient compliance with physicina recommendations. For example, 
Klabunde et al. (2015) reported that almost 25% of adults between 76 and 84 did not 
meet the U.S. Preventative Services Task Force recommendations for CRC screening 
before the advent of Medicare ACOs. My findings showed that only four out of 470 
ACOs did not meet the minimum performance score of 30 for ACO #19; however, 36% 
of the 140 target ACOs scored under 70%.  
Other studies showed that differences in the structures of provider practices 
influenced their capacities to influence patient behavior (Casalino & Chenven, 2017; 
Casalino et al., 2013; Kim et al., 2017; Pineault et al., 2016). ACOs are comprised of a 
variety of specialists and facility partnerships contractually committed to supporting care 
delivery for ACO beneficiaries. Studies showed that providers believed collaborative 
partnerships might mediate resource constraints tied to their practice size (Kim et al., 
2017). As such, my study supported their summation and found no statistical significance 
between the number of primary care providers in an ACO and their performance with 
ACO #19. Thus, collaboration may have mediated variances related to practice size 
constraints. Previous research also suggested that ACO performance flattened after the 
initial ACO period. This could also account for some similarities in ACO performance 
across the target population.  
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My findings showed that the total number of patients in an ACO had a statistically 
significant correlation to ACO #19 performance. This aligned with previous research that 
practice size as defined by the number of patients predicted success with CMS quality 
measurements (Greene et al., 2015). Furthermore, previous research showed disparities 
across socioeconomic and racial/ethnic boundaries (Bromley et al., 2015). I found a 
statistically significant correlation that more non-White patients in an ACO resulted in 
lower performance scores. This aligned with previous studies where non-White patients 
were less likely to complete CRC screening (Basch et al., 2016; Bromley et al., 2015; 
Hall et al., 2016; Kiviniemi et al., 2018; Klabunde et al., 2015; Mastrokostas et al., 2018). 
Thus, the results supported a growing body of evidence that documented disproportionate 
racial and socioeconomic disparities for patient compliance (Ashktorab et al., 2017; 
Bromley et al., 2015; Burnett-Hartman et al., 2016; Chablani et al., 2017).  
Interpretation in the Context of the Socioecological Model 
My study was guided by the SEM. Under the SEM, provider performance is 
affected by factors that influence both their decision making and their effectiveness to 
change patient behavior (Rabarison et al., 2013). My findings showed that participation 
in an ACO and practice size may influence provider effectiveness to change patient 
behavior. Furthermore, the findings demonstrate factors related to the characteristics of 
their patients influences their effectiveness. Society/policy factors tied to creating ACOs 
and their CMS quality measurements (i.e., success defined by a score of at least 30 for 




There are limitations to my study. First, I excluded new ACOs from the full 
analysis. Thus, the range of performance of the sample population (n = 140) may not 
reflect the distribution of the entire ACO base (n = 470). Nor may it reflect provider 
patient relationships for providers and patients that do not participate in ACOs. Caution 
should be used when generalizing these results for other applications. Second, the MSSP 
PUF file data are restricted to the variables within the data set. 
The file does not provide CRC screening results at the individual level for patients 
or providers. Thus, my findings are limited to generalizations about ACOs based on total 
number of providers, total number of patients, and percentages of patients with certain 
characteristics. As a result, I am unable to articulate differences in ACO #19 compliance 
at the individual patient and rely instead solely on the ACO #19 performance score. I am 
also unable to articulate difference at the individual provider level. Lastly, the MSSP 
PUF has a one-year delay in reporting. The results were provided before the significant 
change in care delivery due to the COVID-19 pandemic and may influence the 
generalizability for future applications.  
Implications 
ACOs are partnerships among care providers including public health 
organizations. My study can improve public health and healthcare professionals’ ability 
to influence the behaviors and health outcomes of the community members they serve. 
This is a vital component of current efforts to screen for COVID-19, promote adoption of 
behaviors to slow the spread of COVID-19 and adoption of COVID-19 vaccinations. The 
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CMS (2012) stated that more than 70% of patients over the age of 65 have two or more 
chronic conditions. The management of patients with multiple chronic diseases is more 
difficult than in those suffering from a single condition (Wagner et al., 2013). Wang et 
al., observed (2020) that elderly COVID-19 patients were among the most severe to 
critical cases with a high rate of fatality. Thus, the results of my study apply to current 
efforts for high risk elderly patients, their providers, and communities 
Cancer screening rates have declined due to the COVID-19 pandemic (Carethers 
et al., 2020). The COVID-19 pandemic disproportionality affected minority communities 
and further resulted in even lower screening rates for minority populations (Carethers et 
al.). As such, Carethers et al., posit that extended delays in cancer screening is expected 
to lead to increase cancer for all populations. This is expected to be elevated in minorities 
and lower socio-economic people. My study offers insight as to which populations may 
be at greater risk based on their previous experience with CRC screening before the 
pandemic. 
My study showed that ACOs with more patients were more compliant with CRC 
screening recommendations. Yet, it showed that ACOs with more Black patients were 
less compliant than those with less. It also revealed that the number of providers in an 
ACO did not influence compliance with CRC screening recommendations. My findings 
supported previous research that showed disparities among non-White patient 
populations. My research helps to decrease the prevalence of CRC and by doing so 
reduce the economic and quality of life burden for individuals and communities affected 
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by the disease. Moreover, my study helps to reduce disparities for CRC screening and 
incidence of CRC among vulnerable populations.  
My study promotes positive social change by providing a foundation for 
population health initiatives beyond CRC related illness Thus, improving the wellbeing 
of communities and increase public health emergency preparedness.  It provides 
meaningful data to the public health and health care provider partnerships engaged in 
transforming healthcare from a transactional delivery system to an evidence-based system 
of value (Berenson et al., 2016). It will influence policies that support health and wellness 
initiatives in communities of color. Furthermore, it will influence policies that govern the 
minimum number of patients in ACOs that might influence CRC screening rates for 
elderly patients. Furthermore, it can influence policy related to provider patient ratios and 
patients aged 65 year and older ... 
Lastly, my study can offer guidance to public health and healthcare provider 
leaders on ways to train professionals better, reduce frustration, improve success and 
achieve higher levels of satisfaction in their work both in routine interventions and public 
health emergencies. 
Recommendations 
Several recommendations resulted for additional research from my study. 
Additional analysis should be conducted for further assessment of ACO #19 performance 
related patient base characteristics, age, race, sex, and socio-economic status. Second, 
CRC screening is the most complex behavior measured for ACOs. These include a 
variety of tests some of which have multiple compliance steps like those with 
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colonoscopy screening. This contrasts with dichotomous behaviors such as receiving a 
flu-vaccinations. I recommend future studies to compare complex behavior such as CRC 
with dichotomous decision like receiving an influenza vaccination.  
The study should also be replicated for all 470 ACO participants. This may 
provide insight on differences and similarities to new and experienced ACOs. The study 
should also include provider feedback using tool like the primary care provider 
Behavioral Health Intervention Survey. The original tool was designed to assess provider 
perceptions of factors that influence their intention to use interventions when treating 
children with mental health problems and can be modified for adults (Arora et al., 2016). 
Lastly the study should be replicated and expanded as a mixed methods 
explanatory sequential study. Mixed methods integrates open-ended qualitative data with 
closed-ended quantitative data from inquiry (Creswell, 2009). Mixed methods strategy is 
purpose-driven research to provide a more in-depth insight into how health professionals 
influence participant behavior (Creswell, 2009). Mixed methods can develop a more 
comprehensive understanding of changes needed for population engagement as well as 
understanding the process and outcomes of current patient engagement strategies 
(Creswell, 2009).  
Conclusion  
Health care delivery and public health have overlapping efforts like health 
screening activities for better health outcomes and to lower the burden of disease 
(Cunningham et al., 2020). Partnerships between community-based organizations, health 
care delivery and public health organizations improve public health outcomes. Studies 
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showed patient behavior was the key to improve quality and health outcomes (Mogre et 
al., 2019). 
The MSSP ACO is partnership based advanced payment model designed to curb 
cost and improve patient outcomes for colon cancer among other disease measures. CRC 
is a leading cause of death in the United States, (Loyd, 2016) and more research is needed 
to determine the impact of MSSP ACO providers on CRC screening. 
Previous research found disparities in health behavior recommendation 
compliance among people based on patient base characteristics and the size of their 
providers’ practices (Kiviniemi et al., 2018; Manteuffel et al., 2014). My study sought to 
determine the relationship between practice size and compliance with MSSP performance 
measure for colonoscopy screening ACO #19. I explored practice size as the number of 
primary care providers and the total number of patients. My findings correlate with 
previous research around physician influence on paitent behavior and patient compliance 
with physician recommendations. My results showed that the number of primary care 
physicians in an ACO did not influence their ACO #19 score. Thus, their participation 
and collaboratoin in an ACO may have mediated some of the contraints found in other 
studies based on practice that could influence ACO performance. My study found that 
ACOs with more patients performed better. This aligned with previous research where 
practice size as defined by the number of patients predicted success with CMS quality 
measurements. However, performance declined as the number and percentage of minority 
patients increased. This aligned with previous research which showed disparities exist 
across socioeconomic and racial/ethnic boundaries. 
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My study addressed the gap in research by focusing on participant behavior of 
ACOs with different size patient populations and the number of primary care providers in 
their organizations. It contributes to positive social change by providing meaningful data 
to public health partnerships and policy makers that determine the size and structure of 
ACOs. Therefore, the application of my findings can improve the ability of public health 
and healthcare providers to predict their influence the behaviors and health outcomes of 
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Objective: This study assessed the preventative quality performance measure (ACO #19) 
for colon cancer screening under Medicare Shared Savings Plan ACO guidelines. I 
quantified the overall performance of ACO #19 based on the population’s demographics 
of race, age and gender. 
 
Methods:  A cross-sectional quantitative study was conducted for organizations who 
participate as a Medicare Shared Savings Plan Accountable Care Organization. The 
research included secondary data analysis of the 2019 Medicare Shared Savings Plan 




Outlet for Manuscript 
The American Journal of Public Health (AJPH) is the intended journal for this 
manuscript (https://ajph.aphapublications.org/). The initial submission requires a title 
page with the manuscript title, author name and affiliations, and full abstract and the 
manuscript with author and university information removed. In addition, the manuscript 
should contain the following elements: 
a. Title and abstract 
b. page numbers 
c. numbered lines (in Word, > Page Setup > Line Numbers > Continuous) 
throughout the text of the manuscript; 
d. 1.5 or double spacing with a font size of 12 
e. tables and figures embedded at the end of the manuscript, OR uploaded as 
separate files 
Submission also requires a cover letter with concise text (maximum 150 words) that 
provides a description of what the paper adds to the knowledge on the topic, especially in 
respect to material previously published in the journal and elsewhere; includes the public 
health importance of the paper; and highlights the main message of the paper in one 
sentence. With the exception of history essays, all AJPH articles follow the AMA Manual 





Public health efforts include initiatives like vaccination and screening to reduce the 
burden of disease. This study used the socioecological model and a cross-sectional 
quantitative design to assess data from the Medicare Shared Savings Plan public use file 
2019 to examine patient behavior as the primary driver to improve healthcare quality and 
reduce costs. This study focused on colorectal cancer (CRC) screening behaviors of 
accountable care organization (ACO) patients based on the age, gender, and race 
differences of the patient population. ACOs with more non-White patients were less 
successful with CRC screening, and performance was highest when more patients were 
between 65-85 years of age when compared to patients under 65 or over 85 years old. 
The implications for positive social change in this study include data for policy makers, 
health, and public health care professionals to reduce disparities for CRC screening and 
incidence of CRC among vulnerable populations. Therefore, the application of the 
findings can improve the ability of public health and healthcare providers to predict their 
influence on behavior and health outcomes of the community members they serve. 
Furthermore, the study supports policies and processes around cultural awareness and 






Healthcare costs in the United States are rising at an unsustainable rate (Noble et 
al., 2014), and significant disparities in health outcomes exist across the U.S. population 
attributed mainly to social determinants of health (Foo et al., 2017). As a result, public, 
community and clinical health professionals in several communities formed partnerships 
under new public healthcare delivery models designed to improve public health by 
addressing social determinants of health and changing individual behavior (Bachrach et 
al., 2016; Noble et al., 2014). For example, the Institute of Healthcare Improvement’s 
Quadruple Aim outlined a framework to improve health outcomes, lower healthcare 
costs, improve patient experience, and improve clinician satisfaction (Wagner et al., 
2018). In fact, experimental alternative payment delivery models (APMs) were created 
with varying success to achieve components of the Quadruple Aim (Noble et al., 2014). 
Studies have shown that improvements in population engagement led to better health 
outcomes (Simmons et al., 2014). Population engagement by providers is essential to 
guide community members toward behaviors that lead to healthier outcomes, which may 
reduce the overall cost of care (Grand et al., 2014). However, there was little evidence of 
which strategies were most successful at influencing their patients’ behavior.  
Problem 
Physicians have suggested that patient behavior is the key to improve health 
quality and outcomes, yet it is difficult to influence individual behavior (Hibbard et al., 
2015). Moreover, researchers have found disparities in patient compliance with health 
behavior recommendations (Kiviniemi et al., 2018; Manteuffel et al., 2014), which are 
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linked to patient characteristics and provider variables like the size of provider practices 
(Kiviniemi et al., 2018; Manteuffel et al., 2014) Data on the patient experience are 
captured in performance reporting through the Centers for Medicare and Medicaid 
Services (CMS, n.d.), and patient perspectives toward patient engagement were well 
documented in the literature (Rowland et al., 2017). However, provider experiences, 
perceptions, success, and strategies to engage community members attributed to their 
APMs has not been represented in detail in previous research (Andrealli et al., 2018; 
Bekmuratova et al., 2019; Berenson et al., 2016; Chen et al., 2016). Thus, there is an 
inability to replicate the best practices for population engagement, that improve 
participant experiences, job satisfaction, health outcomes, and lower costs. To address 
this gap, I explored the preventative quality performance measure for colon cancer 
screening ACO #19 for the Medicare Shared Savings Plan (MSSP) guidelines based on 
race, age, and gender of the patient population. 
Significance of the Study 
APMs introduced patient engagement initiatives to lower the U.S. healthcare costs 
with different levels of success (Noble et al., 2014). Significant disparities in health 
outcomes exist across the U.S. population attributed mainly to social determinants of 
health (Foo et al., 2017). Extensive quantitative data on APM quality are captured by 
CMS performance reports (CMS, n.d.). The literature, however, lacks evidence as to why 
physicians were successful at influencing patient behavior. One study of an emerging 
United Kingdom healthcare model showed that the number of focus groups was increased 
when providers received payments to develop community-based participatory patient 
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focus groups to improve provider care delivery, but the quality of care was not improved 
(Smiddy et al., 2015). In the current study, exploring provider experiences with managing 
patient populations of different ages, genders, and ethnicities might explain to what 
degree they effect patient behavior compared to the measures that determine their 
payments. 
Relevant Contribution to the Body of Knowledge  
The purpose of my study was to assess the relationship between an ACO 
population's demographics race, age, and provider effectiveness at influencing patient 
behavior as measured by the compliance of MSSP performance measure ACO #19. This 
manuscript addresses a gap in research by focusing on provider practice characteristics 
based on age, gender, and race. This manuscript is a cross-sectional quantitative study to 
explore the preventative quality performance for colon cancer screening under MSSP 
ACO guidelines based on the described social determinants of health distribution of the 
patient population. My cross-sectional study provides a more comprehensive assessment 
of physician influence on patient behavior than studies like those from CMS.  
Framework 
The socioecological model (SEM) guided my cross-sectional quantitative study. I 
assessed data from the MSSP public use file (PUF). Under the SEM, provider 
performance is affected by factors that influence both their decision making and their 
effectiveness to change patient behavior (Rabarison et al., 2013). SEM posits five 
categorical levels which affect behavior change: the individual, interpersonal, 
organizational, community/environment, and society/policy levels (Lampard et al., 2013). 
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While the factors of the SEM are hierarchical, they are also integrated, and a change in 
one area could impact others (Coreil, 2009).  
The positivist ontology also guides my study. Positivism implies that there is a 
single truth (Burkholder et al., 2016). Medicare reports ACO #19 measure attainment 
through a PUF. Thus, these results reflect a single truth of their performance. My study 
assessed how patients’ race, age, and gender predicts providers’ ACO #19 measure 
attainment. These findings are the source of truth under the positivist ontology for my 
study 
My research is influenced by multiple contexts. The personal contexts for my 
study include my knowledge and experience with advance payment models and patient 
engagement. The social contexts include CMS guidelines, the fluidity of US healthcare 
policy, political climate, geographic locations, and local healthcare delivery priorities. 
Lastly, interpersonal contexts include Walden University dissertation committee 
representatives. 
The definition of “provider success” is precise and supports a quantitative 
ontology of positivism where there is one true reality (Burkholder et al., 2016). 
Positivism guided my cross-sectional quantitative study to answer the question “How 
effective were providers at influencing patient behavior based on the performance 
measure ACO #19 of the Medicaid Shared Savings Plan?” I analyzed archival data from 





Colorectal cancer (CRC) is a leading cause of death in the United States (Lloyd, 
2016). The Centers for Disease Control and Prevention estimated over 40,000 deaths 
attributed to colon cancer in 2016 (Bachman et al., 2018). The risk of CRC mortality can 
be reduced with early detection (Lloyd, 2016). Focused efforts to increase CRC screening 
led to a reduction of CRC related deaths in the last decade; yet, several disparities 
continue to exist across socioeconomic and racial/ethnic boundaries (Bromley et al., 
2015). Klabunde et al. (2015) reported that almost 25% of adults between 76 and 84 did 
not meet the U.S. Preventative Services Task Force recommendations for CRC screening 
before the advent of Medicare ACOs.  
APMs were created to fight rising health care costs in the United States (Noble et 
al., 2014). ACOs are one of the advanced payment models designed to shift the focus of 
healthcare services from a traditional fee for service structure to a value-based care 
model. CRC screening is a key focus and measurement of ACOs. The propensity for 
provider recommendations for appropriate screening based on the Preventative Services 
Task Force recommendations for CRC screening was very low before the advent of 
Medicare ACOs (Klabunde et al., 2015). This problem was further exacerbated by racial 
disparities where African American and Hispanic individuals were less likely to complete 
screening and had an increased prevalence of adverse health outcomes as a result 
(Klabunde et al., 2015).  
A growing body of evidence among other research further documented 
disproportionate racial and socioeconomic disparities and highlighted the diverse cultural 
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needs to motivate patients toward compliance (Ashktorab et al., 2017; Bromley et al., 
2015; Burnett-Hartman et al., 2016; Chablani et al., 2017). Many studies offered 
anecdotal patient interventions that improved patient compliance (Nathan et al., 2016; 
Singal et al., 2017; Slyne et al., 2017). Studies that focused on patient experience 
reinforced culturally competent approaches based on varying patient demographics 
(Alsayid et al., 2019; Brittain & Murphy, 2015; Chen et al., 2016).  
Fear was demonstrated to be a major influence for compliance by all patients, but 
particularly among blacks and Hispanics (Basch et al., 2016; Bromley et al., 2015; Hall et 
al., 2016; Kiviniemi et al., 2018; Mastrokostas et al., 2018). Fear emerged as fear of both 
fear of undergoing the procedure and fear of the procedure’s findings (Bromley et al., 
2015). Ineffective communication and perceived provider uncertainty also affected the 
patient decision-making process (Beverly et al., 2016). This was confounded by patients' 
expectations of the provider (Alspach, 2018; Mast & Kadji, 2018). For example, 
uncertainty was seen as a form of truthfulness for female providers, whereas the trait 
generated mistrust for male providers (Mast & Kadji, 2018). Moreover, trust was 
demonstrated to be a contributing factor behind non-compliance of CRC screening for 
many Hispanic patients (Hong et al., 2018). Studies also showed providers adherence to 
evidence-based treatment guidelines differed when treating men vs women (Manteuffel et 
al., 2014). Still more evidence reported unconscious bias by providers when treating 
patients of different race, age, and socioeconomic groups. (Williams et al., 2015). 
Medicare recognizes four methods of colonoscopy screening to demonstrate 
compliance with the ACO #19 measure (Prince et al., 2017). These include colonoscopy, 
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DNA, stool testing, and fecal occult blood test. Studies suggest CRC compliance varies 
with the type of test offered, Thus, could impact the CRC screening recommendations 
that providers make to their patients (Alsayid et al., 2019; Basch et al., 2016; Bian et al., 
2016; Brenner & Chen, 2017; Bromley et al., 2015; Chambers et al., 2016). 
Colonoscopy is the most popular forms of CRC screening, and includes multiple 
steps like scheduling, bowel preparation, sedation and the procedure itself; some of which 
contain multiple levels of compliance (Powers & Keohane, 2018). Some of steps to 
obtain a colonoscopy contain multiple levels of compliance and complexity themselves 
(Powers et al., 2018). For example, strategies such as enhanced written education, media 
campaigns, and videos improved compliance with the bowel preparation step for 
colonoscopies (Andrealli et al., 2018; Cole et al., 2019; Essink-Bot et al., 2016). 
However, they were demonstrated as less effective to improve patient health literacy and 
compliance to complete a colonoscopy procedure (Clark et al., 2017; Enard et al., 2015; 
Mishra et al., 2018).  
Success varied among the initial United States APMs (Noble et al., 2014). 
Hibbard et al. (2015) documented that compensation from APMs in other countries 
influenced physician opinions on the importance of patient behavior. They further 
provided evidence that patient behavior was the primary driver of improving quality 
(Hibbard et al., 2015). Other studies showed that improvements in patient engagement 
lead to better health outcomes (Grand et al., 2014; Simmons et al., 2014). 
Physicians in the United States agreed that patient behavior was the key 
determinant to improve quality and outcomes, yet, many found frustration when they 
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tried to influence individual behavior (Hibbard et al., 2015). While many providers 
perceived their role within the community and in population health as “medicine-based”; 
a growing emphasis on preventative care and the complex characteristics of their 
attributed patient base fostered better collaboration between healthcare providers and 
traditional public health organizations (Ingram et al., 2015). This was particularly true for 
mutual objectives such as cancer prevention (Basch et al., 2016).  
Nyweide et al. (2015) showed the initial performance under the Medicare ACO 
model reduced healthcare expenditures for the attributed population base when compared 
to traditional Medicare fee-for-service beneficiaries. The CMS measures ACO providers 
across four domains, which include care coordination, patient safety, patient experience, 
and preventative health (Modi et al., 2018). Providers are rewarded for lower cost of 
patient care and achieving quality metrics outlined in their ACO contracts.  
Studies documented provider perceptions of barriers and provider characteristics 
that influenced their decision making and success (Mastrokostas et al., 2018; Wang et al., 
2018). These included the basic ability to verify patient’s correct CRC status and the 
clinician’s ability to confer with specialists (Mastrokostas et al., 2018) For example, a 
provider recommendation was a primary influence on whether patients of all 
demographic groups participated in CRC screenings (Bian et al., 2016; Bromley et al., 
2015). Some studies showed that health information technologies that shared patient 
information or alerted providers to the patient’s CRC risk and screening status nudged 
providers to provide CRC screening recommendations (Kim et al., 2017b; Mankaney et 
al., 2019). Additionally, other studies reiterated the importance of Patient Behavior on 
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quality performance and the need to implement systems to support patient engagement 
activities to influence behavior (Mishra et al., 2018). These included the concepts of, 
motivational interviewing, goal setting, and shared decision making (Mishra et al., 2018). 
However, Mishra and colleagues (2018) reported that providers were aware of these 
concepts but often lacked the depth of understanding and practice to implement them in a 
meaningful way. Shapiro et al. (2018) further described provider experiences with tough 
to manage patients in which providers described themselves as anxious, frustrated, and 
uncertain with little preparation for how to handle difficult patients. My study addressed a 
gap in research and focused on the patient attribution characteristics and provider 
strategies that influence the behavior of APM patients to achieve compliance with CRC 
screening recommendations. 
Research Question and Design 
The nature of the manuscript is a cross-sectional quantitative study for the 
following research questions:  
Based on the performance measures of the MSSP, what is the relationship 
between the ACO population's demographics race, age, and how effective providers are 
at influencing patient behavior as measured by the compliance of MSSP performance 
measure ACO #19? 
H0: There are no statistically significant differences in compliance of MSSP 




Ha: There are statistically significant differences in compliance of MSSP 
performance measure ACO #19 based on the ACO population's demographics, race, age, 
and gender. 
Cross-sectional quantitative studies are descriptive research to describe 
community characteristics at a single point in time. I analyzed data from the MSSP PUF 
from 2019. I assessed the relationship of dependent variable ACO performance for 
measure ACO #19 and the independent variables race, age and gender. My research 
design required a way of to measure patient behavior. CMS ACO #19 is a cumulative 
measure based on the number of people that participated in CRC screening. Therefore, I 
assumed that CMS data is a valid measure of patient behavior.  
Methods 
Operational Definitions 
ACO #19: Percentage of adults between 50–75 years of age who had appropriate 
screening for CRC for ACO quality reporting (CMS, 2017). 
Alternative payment delivery models (APMs): Several experimental 
advance/APMs have been created with varying success to introduce new patient 
engagement initiatives to combat the United States skyrocketing healthcare costs (Noble 
et al., 2014). 
Attribution: The patients assigned to the health care provider for which they are 
being measured (Noble et al., 2014). 
Patient engagement: Studies show that improvements in patient engagement lead 
to better health outcomes (Simmons et al., 2014). 
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Practice size: The number of patients and the number of primary care physicians 
in an ACO. 
Bias and Limitations 
I analyzed archived data from the CMS. Therefore, the quality of this quantitative 
data source was beyond my control as the researcher and contingent on the data 
collection process for MSSP reporting (Burkholder et al., 2016). CMS (2017) allows 
providers to review and dispute published performance data, followed by a final CMS 
ruling. I used the final report issued by CMS, which included corrections to improve data 
quality. But I could not control confounding variables that may influence provider–
patient attribution (Noble et al., 2014). These included patient comorbidities that can 
affect patients abilities to comply with healthcare treatment plans (DeJean et al., 2013).  
Scope and Delimitations 
The MSSP ACO PUF details physician performance against 32 measures across 
four domains (CMS, n.d.). The results are the official CMS findings and used to pay 
provider incentives (Noble et al., 2014). Therefore, these measures are valid 
representations of physician performance. The scope of my study was to evaluate 
physicians’ performance against the CMS measurement for colon cancer screening ACO 
#19.  
I limited my target population to the subset of organizations that had previous 
experience with MSSP ACOs and those who reported data for the 2019 MSSP reporting 
year. Excluding first-year MSSP participants improved credibility by ensuring that 
providers in the sample had a baseline measurement that reflected their performance 
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better (Noble et al., 2016). Disparities in provider–patient interactions may be influenced 
by the factors race and patient insurance coverage (Foo et al., 2017). Therefore, a third 
delimitation limited the participatn sample to those with a patient base with at least 10% 
non-White and accept both Medicaid and Medicare patients (CMS, 2017). Succesful 
attainmnet of ACO #19 was detrmined by a score of at least 30% (CMS, 2017). I 
differentiated well-performing providers from poor performing using this recognized 
benchmark as a fourth delimitation (CMS, 2017).  
Design 
Positivism guided the cross-sectional quantitative study to answer the question, 
“How effective are providers at influencing patient behavior based on the performance 
measure ACO #19 of the Medicaid Shared Savings Plan?”  Archival data analysis from 
the CMS 2019 MSSP PUF supported the positivist approach to my research question. I 
used the quality performance data for healthcare providers reported in the PUF to 
determine their effectiveness at influencing patient behavior as it correlated to their 
practice size. 
Instrumentation 
Archival data from the MSSP PUF for 2019 was used for the data collection 
process. The MSSP ACO PUF was derived from a combination of provider claims and 
survey data. The PUF files are available for performance years 2013-2019. The PUF file 
included hundreds of variables, descriptions and performance measure outcomes. These 
included measures for six behavior related preventative measures. Performance measures 
79 
 
were captured as a percent of the total population where a higher score means higher 
performance for that measure. 
Provider incentives for MSSP ACOs were based on quantitative analysis of their 
performance against established benchmarks (Noble et al., 2014). As such the current 
reporting for the effectiveness of APMs is dichotomous as the providers did or did not 
meet their measurement objectives (CMS, n.d.). This clear determination of provider 
success supports a quantitative ontology of positivism in which there is one true reality 
(Burkholder et al., 2016). Furthermore, quantitative analysis of provider performance 
using MSSP public use data is an accepted practice among the healthcare community 
(Noble et al., 2016).  
Participants 
I limited the evaluation of provider performance  to organizations in the United 
States who had previous ACO experience prior to 2019 and who reported data for the 
2019 MSSP reporting year. Previous studies showed that providers treated patients 
differently according to sociodemographic characteristics (Foo et al., 2017; Manteuffel et 
al., 2014). Therefore, I restricted participants  to ACOs with a patient base of at least 10% 
non-White and who accepted both Medicaid and Medicare patients. Furthermore, CMS 
set a minimum standard of 30% achievement to comply with MSSP guidelines. 





Archival data was reviewed from the MSSP PUF for 2019. I used data for new 
and returning ACO participants from the 2019 MSSP PUF. I described the extent that 
ACOs were successful with measure ACO #19. I uploaded the entire MSSP PUF 
database into SPSS v25 for review, analysis, and statistical testing.  
Quantitative Collection and Analysis 
I assessed how effective ACOs were at changing patient behavior. I described the 
extent that ACOs were successful at achieving colon cancer screening for measure ACO 
#19. I uploaded the entire 2019 MSSP PUF database into SPSS v25 for review, analysis 
and statistical testing. I retained the native MSSP PUF document, which was uploaded 
multiple times with all statistical tests replicated to ensure integrity and reliability. I used 
Pearson Correlation and linear regression to determine if there was a significant 
relationship between ACO practice size and performance. The level of significance was 
set to 0.05.  
Results 
Research question: Based on the performance measures of the MSSP, what is the 
relationship between the ACO population’s demographics race, age, and gender and 
compliance with MSSP performance measure ACO #19? 
H0: There are no statistically significant differences in compliance with MSSP 




Ha: There are statistically significant differences in compliance with MSSP 
performance measure ACO #19 based on the ACO population’s demographics, race, age, 
and gender. 
Execution 
Archival data from the MSSP PUF (CMS, n.d.) for 2019 were assessed for 470 
ACOs. I calculated an additional variable to reflect the attribution percentages for race, 
age, gender, and Medicaid status in Microsoft Excel. The modified file was then entered 
into SPSS version 25 to organize, code, and screen data. Data for ACO #19 score and 
number of primary care providers were recoded to ordinal categorical data. Values were 
calculated including frequency counts and percentages with SPSS. Descriptive data 
analysis was performed for frequencies for all ACOs.  
The final sample size was narrowed to 140 ACOs based on the inclusion and 
exclusion criteria for the study. These included previous experience in the MSSP 
program and an ACO #19 score of 30 or more, an attribution that was at least 10% non-
White. I performed statistical assumption tests for normal distribution, homoscedasticity, 
and linearity between dependent and independent variables before research question 
analysis. Table 7 summarizes the dependent, independent variables, and statistical 






Variables and Statistical Tests Used to Evaluate Research Questions 
Research Question Dependent Variable Independent Variable Analysis 
What is the relationship 
between practice size 
and compliance with 
MSSP performance 
measure ACO #19? 
ACO #19 Score 
Attribution Characteristics: Age 
Attribution Characteristics: Race 





Note. ACO = accountable care organization  
Descriptive Statistics for all ACOs 
Descriptive analysis for all (n = 470) ACOs and the target sample (n = 140) were 
conducted for ACO #19 performance. Frequencies were reviewed for practice size and 
characteristics of ACO attributions for age, race, gender, and insurance. Table 8 shows 
the ACO #19 performance with most organizations achieving between 50% and 90%. 
Performance for the target population aligned with the larger base with most 
organizations (n = 85) achieving between 70–89% followed by those between 50-69% (n 
= 47).  
Table 8 
 
ACO #19 Performance Range and Frequency 
 All ACOs   Target ACOs 
ACO #19 Score Frequency Percent   Frequency Percent  
0-29 4 0.9     
30-49 13 2.8   4 2.9 
50-69 157 33.4   47 33.6 
70-89 287 61.1   85 60.7 
90 to 100 9 1.9   4 2.9 
Total 470 100.0   140 100.0 
Note. ACO = accountable care organization  
Practice size as measured by primary care physicians ranged from 20 to 2,299. 
Table 9 shows that most ACOs had less than 200 primary care providers with the 





Range and Frequency of Primary Care Providers in ACOs 
 All ACOs Target ACOs 
 Primary Care Providers Frequency Percent Frequency Percent  
0-49 72 15.3 15 10.7 
50-99 101 21.5 32 22.9 
100-149 74 15.7 18 12.9 
150-199 41 8.7 11 7.9 
200-249 30 6.4 9 6.4 
250-299 25 5.3 9 6.4 
300-349 15 3.2 5 3.6 
350-399 16 3.4 6 4.3 
400-499 30 6.4 8 5.7 
500-599 16 3.4 7 5.0 
600 or more 50 10.6 20 14.3 
Total 470 100.0 140 100.0 
Note. ACO = accountable care organization  
Table 10 shows the practice size characteristics based on patient attribution for all 
ACOs. ACOs that did not report a score for ACO #19 (n = 4) were removed. Of the 
remaining (n = 466) there was a total of 9,918,470 patients enrolled in the ACOs of which 
4,275,182 (43%) were male and 5,643,285 (57%) female. Eighty-six percent of the 
population was white and 14% non-White. Ages ranged from 0-64 (14%), 65-74 (46%), 
75-84 (28%) and 85 or older (12%). Beneficiaries with Medicaid totaled 606,989. The 






Range and Percentage of Attributions Across all ACOs 
  Minimum Maximum Sum Percent 
Total Patients 2,193 239,924 9,918,470   
Female 1,240 133,423 5,643,285 57% 
Male 953 106,501 4,275,182 43% 
Medicaid Patients 67 17,981 606,989 6% 
Non-Medicaid Patients 1,346 181,135 7,917,736 80% 
Total Age 0_64 262 41,238 1,369,626 14% 
Total Age 65_74 817 109,019 4,607,276 46% 
Total Age 75_84 619 64,190 2,799,157 28% 
Total Age 85Plus 186 25,477 1,142,411 12% 
White 479 219,069 8,519,870 86% 
Non-White 97 24,215 1,398,600 14% 
Note. ACO = accountable care organization  
The attribution of most ACOs in the target population was under 40,000 patients. 
Table 11 shows that over half of the ACOs carried an attribution of between 10,000 and 
39,999 followed by a range of 2,193 to 9,999 (27%).   
Table 11 
 
Range and Percentage of Attribution  
Attribution Range Frequency Percent  
0-9,999 38 27.1 
10,000-39,999 77 55.0 
40,000-79,999 19 13.6 
80,000 or more 6 4.3 
Total 140 100.0 
 
Tests of Assumptions 
I conducted assumption tests of the dependent variable ACO #19. The data were 
normally distributed and follow a normal distribution curve. The skewness and kurtosis 
tests for normal distribution should fall between the rage of ± 2 and ±7 respectfully. The 
ACO #19 score data for skewness was -.287 and kurtosis was -.692. The Kolmogorov-
Smirnov test for normality was insignificant at .058. Figure three shows the normal Q-Q 





Normal Q-Q Plot for ACO #19 Performance 
 
Note. ACO = accountable care organization  
Inferential Statistics Manuscript 2 
I found that age and race characteristics of patients in an ACO had a statistically 
significant influence on ACO #19 performance. Thus, the null hypothesis that age and 
race do not have a significant influence on ACO #19 performance was rejected. Gender 
did not significantly influence ACO #19 performance. The null hypothesis that gender 
does not influence ACO #19 performance was accepted. I used bivariate correlation to 
determine the relationship between the dependent variable ACO #19 performance and 
independent variables for age, gender and race. 
Age 
Table 12 shows the correlations between age and ACO #19 performance. The 
total number of patients in an ACO that were between 0-64 years old was not a 
significant influence on ACO #19 performance. The total number of patients between the 
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age of 65-74 was statistically significant with a positive correlation of .228 and p = .007. 
The total number of patients between the age of 75-84 also had a positive correlation of 
.240 and p = .004. The total number of patients over the age of 85 had a positive 
correlation of .211 and p = .012.  
The percentage of patients between 0-64 had a negative correlation of -.472 which 
was statistically significant at p<.001. The percent of patients between 65-74 had a 
positive correlation of .341 with p<.001. The percent of patients between 75-84 had a 
positive correlation of .448 with p<.001. The percent of patients 85 and over was not a 
significant influence on ACO #19 performance. 
Table 12 
 
Correlation Between Attribution Age and Performance 
 
Attribution 












0.045 .228** .240** .211* 
P value 
 
0.598 0.007 0.004 0.012 
N 
 
140 140 140 140        
Attribution 














0.000 0.000 0.000 0.307 
N 
 
140 140 140 140 
            
 
Gender 
Both the total number of male and the total number of female patients showed a 
positive correlation that was statistically significant. However, this measure correlates to 
the total number of patients in an ACO which was found to be statistically significant in a 
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previous study. Alternatively, the percentages of male and female patients did not show a 
statistically significant correlation on ACO #19 performance. 
Race  
Table 13 shows the correlations between race and ACO #19 performance. The 
results showed statistically significant correlations for ACO #19 performance and total 
number of white patients in an ACO. The total of white patients in an ACO had a positive 
correlation of .244 with p = .244. The total of patients in an ACO that were a race other 
than, White, Black, Asian, Hispanic or Native American also had a positive correlation 
with ACO #19 performance of .167 and p=0.049. 
The percent of the total patients in an ACO that were white had a positive 
correlation with ACO #19 performance of .416 and p=0.00. The percent of Black and 
Hispanic patient in the ACO had negative correlations with ACO #19 performance. The 
percent of black patients had a negative correlation of -.365 and p = .00. The percent of 






Correlation Between Attribution Race and CRC Screening 
Attribution Total White Black Asian Hispanic 
Native 





.244** -0.027 -0.047 -0.004 0.012 .167* 0.014 
P value 0.004 0.756 0.578 0.967 0.887 0.049 0.871 
N 140 140 140 140 140 140 140 
 



















.416** -.365** -0.134 -.222** -0.136 -0.069 -.416** 
 P value 0.000 0.000 0.114 0.008 0.109 0.420 0.000 
N 140 140 140 140 140 140 140 
                
Note. CRC = colorectal cancer 
Linear Regression 
I used linear regression to further analyze the correlations between ACO #19 
performance and the number of patients in an ACO for each age category. The 
relationship was statistically significant (F(4,135) = 5.84, p<.05).The total patients in 
each age group attributed to the variance in ACO #19 performance by 14.8% with an R2 
value of .148 and an adjusted R2 of .122. 
ACO #19 score increased slightly as the total number of patients between the age 
of 75-84 increased with a coefficient of B = .002. Scores also increased with a coefficient 
of B = 7.11 as the number of patients between the age of 65-74 increased. There was a 
slight decrease in performance with B = -.002 as the total number of patients between 0-
64 years old and over 85 years old increased.   
The relationship between the percent of patients in each age group and ACO #19 
performance was statistically significant (F(3,136) = 16,650,p<.05).These percentages 
had a higher influence of 26.9% of the variance with an R2 of .269 and an adjusted R2 of 
.252. ACO performance increased B = .311 as the percent of patients in the ACO 
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increased between the ages of 65-74 years old. Performance also increased B = 1.27 as 
the percent of patients increased between the age of 75-84 years of age. However, 
Performance decreased B = -.509 as the percent of patients 85 or older increased. 
I used linear regression to further analyze the correlations between ACO #19 
Performance and race. The relationship was statistically significant (F(11,128), p<.05). 
Race attributed to the variance in performance by 27.2 % with an R2 value of .272 and an 
adjusted R2 of .210. ACO #19 performance improved with B = 6.4 as the number of 
White patients increased. Performance decreased slightly B = -.001 as the number of 
patients categorized as “Other” increased. Performance decreased B = -.804 and B = -
.420 as the percentage of Hispanic and Black patients increased respectively.  
Discussion 
Interpretation 
Almost 25% of adults between 76 and 84 did not meet the U.S. Preventative 
Services Task Force recommendations for CRC screening before the advent of Medicare 
ACOs (Klabunde et al., 2015). My findings showed that only four out of 470 ACOs did 
not meet the minimum performance score of 30 for ACO #19. However, 36% of the 140 
target ACOs scored under 70%.  
My overarching study showed the size of the ACO attribution had a statistically 
significant correlation to ACO #19 performance. This aligned with previous research that 
practice size as defined by the number of patients predicted success with CMS quality 
measurements (Greene et al., 2015). Results also supported compliance disparities 
between races (Ashktorab et al., 2017; Bromley et al., 2015; Burnett-Hartman et al., 
90 
 
2016; Chablani et al., 2017), as I found a statistically significant correlation that more 
Black and Hispanic patients in an ACO resulted in lower performance scores. This 
aligned with previous studies where non-White patients were less likely to complete CRC 
screening (Basch et al., 2016; Bromley et al., 2015; Hall et al., 2016; Kiviniemi et al., 
2018; Klabunde et al., 2015; Mastrokostas et al., 2018). Thus, ACOs that serve high 
numbers of minority patients experience lower quality performance than others (Lewis et 
al., 2017). This may correlate to research that showed lack of trust to be a contributing 
factor behind non-compliance of CRC screening for many Hispanic patients (Hong et al., 
2018).  
In addition to race, my study found statistically significant differences for ACOs 
with different age categories. This further supports findings of unconscious bias by 
providers when treating patients of different race, age and socioeconomic groups. 
(Williams et al., 2015). Other studies, however, found no relation to these characteristics 
and provider decisions (Haider et al., 2015). My study did not show a difference in ACO 
#19 performance based on gender. However, caution should be made when generalizing 
these results as they were not calculated at the individual patient or provider level.  
Interpretation in the Context of the Socioecological Model 
My study was guided by the SEM. Under the SEM, provider performance is 
affected by factors that influence both their decision making and their effectiveness to 
change patient behavior (Rabarison et al., 2013). My study showed that participation in 
an ACO and practice size as total patients and number of minorities may influence 
provider effectiveness to change patient behavior. Furthermore, factors related to the 
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characteristics of their patients may influence their effectiveness. Society/policy factors 
tied to creating ACOs and their CMS quality measurements (i.e., success defined by a 
score of at least 30 for ACO #19) are also influential. My research did not report findings 
related to socioeconomic make up. However, my overarching research demonstrated that 
a high percentage of patients with lower socioeconomic status negatively influence 
provider effectiveness.  
Limitations 
There are limitations to my study. First, I excluded new ACOs from the full 
analysis. Thus, the range of performance of the sample population (n = 140) may not 
reflect the distribution of the entire ACO base (n = 470). Nor may it reflect provider 
patient relationships for providers and patients that do not participate in ACOs. Caution 
should be used when generalizing these results for other applications. Second, the MSSP 
PUF file data are restricted to the variables within the data set. The file does not provide 
CRC screening results at the individual level for patients or providers. Thus, my findings 
are limited to generalizations about ACOs based on total number of providers, total 
number of patients, and percentages of patients with certain characteristics. As a result, I 
am unable to articulate differences in ACO #19 compliance at the individual patient and 
rely instead solely on the ACO #19 performance score. I am also unable to articulate 
difference at the individual provider level. Lastly, the MSSP PUF has a one-year delay in 
reporting. The results were provided before the significant change in care delivery due to 




Cancer screening rates have declined due to the COVID-19 pandemic (Carethers 
et al., 2020).  The COVID-19 pandemic disproportionality affected minority communities 
and further resulted in even lower screening rates for minority populations (Carethers et 
al.). As such, Carethers et al., posit that extended delays in cancer screening is expected 
to lead to increase cancer for all populations. This is expected to be elevated in minorities 
and lower socio-economic people. My study offers insight as to which populations may 
be at greater risk based on their previous experience with CRC screening before the 
pandemic. 
My findings supported previous research that showed disparities among non-
White patient populations. It further demonstrated a lack of compliance with CRC 
screening where more patients in the population were either under 65 or over 85 years 
old. My research helps to decrease the prevalence of CRC and by doing so reduce the 
economic and quality of life burden for individuals and communities affected by the 
disease. Moreover, my study helps to reduce disparities for CRC screening and incidence 
of CRC among vulnerable populations.  
My study promotes positive social change by providing a foundation for 
population health initiatives beyond CRC related illness Thus, improving the wellbeing 
of communities and increase public health emergency preparedness. It provides 
meaningful data to the public health and health care provider partnerships engaged in 
transforming healthcare from a transactional delivery system to an evidence-based system 
of value (Berenson et al., 2016). It will influence policies that support health and wellness 
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initiatives in communities of color and patients aged 65 year and older. ACOs are 
partnerships among care providers including public health organizations. My study can 
improve public health and healthcare professionals’ ability to influence the behaviors and 
health outcomes of the community members they serve. This is a vital component of 
current efforts to screen for COVID-19, promote adoption of behaviors to slow the spread 
of COVID-19 and adoption of COVID-19 vaccinations. The CMS (2012) stated that 
more than 70% of patients over the age of 65 have two or more chronic conditions. The 
management of patients with multiple chronic diseases is more difficult than in those 
suffering from a single condition (Wagner et al., 2013). Wang et al., observed (2020) that 
elderly COVID-19 patients were among the most severe to critical cases with a high rate 
of fatality. Thus, the results of my study apply to current efforts for high risk elderly 
patients, their providers and communities. 
Lastly, my study can offer guidance to public health and healthcare provider 
leaders on ways to train professionals better, reduce frustration, improve success and 
achieve higher levels of satisfaction in their work both in routine interventions and public 
health emergencies. 
Recommendations 
Several recommendations resulted for additional research from my study. 
Additional analysis should be conducted for further assessment of ACO #19 performance 
based the size of the ACO population and the number of providers participating in an 
ACO. The influence of insurance coverage particularly for lower socio-economic patients 
with Medicaid should be explored. Next, some CRC screenings are complex. These 
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include tests some which have multiple compliance steps like those with colonoscopy 
screening. This contrasts with dichotomous behaviors like receiving a flu-vaccination. I 
recommend future studies to compare complex behaviors such as CRC screening with 
dichotomous decisions like receiving an influenza vaccination.  
The study should also be replicated for all 470 ACO participants. This may 
provide insight on differences and similarities to new and experienced ACOs. Future 
research could include provider feedback using tools like the primary care provider 
Behavioral Health Intervention Survey. The original tool was designed to assess provider 
perceptions of factors that influence their intention to use interventions when treating 
children with mental health problems and can be modified for adults (Arora et al., 2016). 
Lastly the study could be replicated and expanded as a mixed methods 
explanatory sequential study. Mixed methods integrates open-ended qualitative data with 
closed-ended quantitative data from inquiry (Creswell, 2009). Mixed methods strategy is 
purpose-driven research to provide a more in-depth insight into how health professionals 
influence participant behavior (Creswell, 2009). Mixed methods can develop a more 
comprehensive understanding of changes needed for population engagement as well as 
understanding the process and outcomes of current patient engagement strategies 
(Creswell, 2009).  
Conclusion  
Health care delivery and public health have overlapping efforts like health 
screening activities for better health outcomes and to lower the burden of disease 
(Cunningham et al., 2020). Partnerships between community-based organizations, health 
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care delivery and public health organizations improve public health outcomes. Studies 
showed patient behavior was the key to improve quality and health outcomes (Mogre et 
al., 2019). 
The MSSP ACO is partnership based advanced payment model designed to curb 
cost and improve patient outcomes for colon cancer among other disease measures. CRC 
is a leading cause of death in the United States, (Loyd, 2016) and more research is needed 
to determine the impact of MSSP ACO providers on CRC screening. Previous research 
found disparities in health behavior recommendation compliance among people based on 
patient base characteristics race, age and gender.  
My quantitative study of 140 ACO participants sought to determine the 
relationship between these patient characteristics and compliance with MSSP 
performance measure for colonoscopy screening ACO #19. My findings correlate with 
previous research around physician influence on paitent behavior and patient compliance 
with physician recommendations. My findings showed differences in performance based 
on age and race but not for gender. Performance increased for ACOs with more patients 
between the age of 65-85 years old. However, performance declined as the number and 
percentage of non-White patients increased. This aligned with previous research which 
showed disparities exist across socioeconomic and racial/ethnic boundaries. The results 
did not show a difference in performance based on the gender makeup of the ACO 
population. 
My study addressed the gap in research and focused on participant behavior of 
ACOs based on the racial, gender and age distribution of their patient populations. It 
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contributes to positive social change by providing meaningful data to public health 
partnerships and policy makers as to how these social determinants of health impact 
outcomes. Therefore, the application of my findings can improve the ability of public 
health and healthcare providers to predict their influence on behavior and health 
outcomes of the community members they serve. Furthermore, it supports policies and 
processes around cultural awareness and cultural competencies to contribute to better 
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Objective: This study assesses the preventative quality performance measure (ACO #19) 
for colon cancer screening under Medicare Shared Savings Plan ACO guidelines. I 
quantified the overall performance of ACO #19 based on the population’s demographics 
of race, age, and gender. 
 
Methods: A cross-sectional quantitative study was conducted for organizations who 
participate as a Medicare Shared Savings Plan Accountable Care Organization. The 
research included secondary data analysis of the 2019 Medicare Shared Savings Plan 
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Public health efforts to improve health include vaccination and screening initiatives to 
reduce the burden of disease. This study focused on colorectal cancer (CRC) screening 
behaviors of accountable care organization (ACO) patients with Medicaid and providers’ 
ability to comply with the Medicare Shared Savings Plan (MSSP) quality measure ACO 
#19. This study used the socioecological model and a cross-sectional quantitative design 
to assess data from the MSSP public use file 2019 to expand on current literature that 
determined Medicaid patients experienced bias and obstacles while pursuing CRC 
screening. Furthermore, it supported previous research that patient behavior was the 
primary driver to improve healthcare quality and reduce costs. This study found ACOs 
with more Medicaid patients were also less successful with less Medicaid distribution. 
Success with CRC screening is influenced by factors like policies, funding sources, and 
external demands that guide decisions. Moreover, rising costs of the United States 
Healthcare system is a public health threat. This study contributes to positive social 
change by providing meaningful data to public health partnerships and policies that 
impact community health outcomes for lower socio-economic patients.  The implications 
for positive social change in this study include data for policy makers, health, and public 
health care professionals to reduce disparities for CRC screening and incidence of CRC 
among vulnerable populations. Therefore, the application of my findings can improve the 
ability of public health and healthcare providers to predict their influence on behavior and 
health outcomes of the Medicaid beneficiaries they serve. The data also supports 




Healthcare costs in the United States are rising at an unsustainable rate and 
include significant disparities in health outcomes attributed to social determinants (Foo et 
al., 2017; Noble et al., 2014). Public health agencies and clinical health organizations 
formed partnerships in several communities to form new public healthcare delivery 
models (Noble et al., 2014). These partnerships were designed to improve their 
population’s health by influencing individual behavior and addressing social 
determinants of health (Bachrach et al., 2016; Noble et al., 2014). For example, the 
Institute of Healthcare Improvement’s Quadruple Aim outlined a framework to improve 
health outcomes, lower healthcare costs, improve patient experience, and improve 
clinician satisfaction (Wagner et al., 2018). This contributed to the development of 
experimental alternative payment delivery models (APMs) to achieve components of the 
Quadruple Aim; however, these new designs have had varying degrees of success (Noble 
et al., 2014). Studies have shown that population engagement is essential to guide 
community members toward behaviors that lead to healthier outcomes, which could 
reduce the overall cost of care (Grand et al., 2014). However, there was little evidence of 
which strategies were most successful at influencing the population’s behavior.  
Problem 
Patient behavior is the key to improve health quality and outcomes, yet many 
physicians have found it difficult to influence individual behavior (Hibbard et al., 2015). 
Moreover, researchers have found disparities in patient compliance with health behavior 
recommendations (Kiviniemi et al., 2018; Manteuffel et al., 2014) linked to patient 
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characteristics and provider variables like the size of provider practices (Kiviniemi et al., 
2018; Manteuffel et al., 2014). Data on the patient experience are captured in 
performance reporting through the Centers for Medicare and Medicaid Services (CMS, 
n.d.). Furthermore, patient perspectives toward patient engagement are well documented 
in the literature (Rowland et al., 2017). However, provider experiences, perceptions, 
success, and strategies to engage community members attributed to their APMs have not 
been represented in previous research (Andrealli et al., 2018; Bekmuratova et al., 2019; 
Berenson et al., 2016; Chen et al., 2016). Thus, there is an inability to replicate the best 
practices for population engagement, that improve participant experiences, job 
satisfaction, health outcomes, and lower costs. This manuscript addressed a gap in 
research and focused on the relationship of the population demographics race, age and 
gender and providers’ influence on APM patient behavior. I explored the preventative 
quality performance measure for colon cancer screening ACO #19 for the Medicare 
Shared Savings Plan (MSSP) ACO guidelines. 
Significance of the Study 
ACOs introduced patient engagement initiatives to lower the U.S. healthcare costs 
with different levels of success (Noble et al., 2014). Some ACO populations include 
underserved and vulnerable patients who are covered by both Medicare and Medicaid 
(Powers & Keohane, 2018). Abundant data on health care quality are captured by CMS 
performance reports (CMS, n.d.). The literature, however, has not shown evidence as to 
why providers were successful at influencing patient behavior. Disparities for 
preventiative care and health outcomes exist for people with different insurance types 
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(Kiviniemi et al., 2018). Davis et al. (2017), demonstrated that lower socioeconomic 
patients and Medicaid patients experienced bias when they pursued CRC screening. 
However, provider perceptions and their experience of engaging patients attributed to 
their APMs have not been explored in detail (Hibbard et al., 2015). One application of 
this rationale was shown in a study of an emerging United Kingdom healthcare model in 
which providers were paid incentives to develop patient focus groups with the intention 
of a community-based participatory approach to improve provider care delivery (Smiddy 
et al., 2014). Smiddy et al., (2015) proved that financial incentives increased the number 
of focus groups but found little impact on the quality of care delivered. Smiddy’s model 
(2015) applies to my study as exploring provider experiences managing patient 
populations with Medicaid or lower socio-economic status might explain to what degree 
they effect patient behavior compared to the measures that determine their payments. My 
study found that ACOs with higher numbers of Medicaid patients had lower CRC 
screening rates. 
Relevant Contribution to the Body of Knowledge  
This manuscript is the first of three manuscripts to a cross-sectional quantitative 
study to explore the preventative quality performance for colon cancer screening under 
MSSP ACO guidelines. My broader study explores how patient demographic 
characteristics race, age, gender, and insurance coverage predict performance. This 
manuscript fills a gap in research by focusing on provider practice characteristics. My 
cross-sectional study provides a more comprehensive assessment of physician influence 
on patient behavior than studies like those from CMS. The purpose of my study was to 
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assess the relationship between patients’ insurance coverage and provider effectiveness at 
influencing patient behavior as measured by the compliance of MSSP performance 
measure ACO #19.  
Framework 
The socioecological model (SEM) guides my cross-sectional quantitative study.  I 
assessed data from the MSSP public use file (PUF). Under the SEM, provider 
performance is affected by factors that influence both their decision making and their 
effectiveness to change patient behavior (Rabarison et al., 2013). SEM posits five 
categorical levels which affect behavior change (Lampard et al., 2013). These levels 
include the individual, interpersonal, organizational, community/environment, and 
society/policy levels (Lampard et al., 2013). While the factors of the SEM are 
hierarchical, they are also integrated, and a change in one area could impact others 
(Coreil, 2009).  
The positivist ontology also guides my study. Positivism implies that there is a 
single truth (Burkholder et al., 2016). Medicare reports ACO #19 measure attainment 
through a PUF. Thus, these results reflect a single truth of their performance. My study 
assessed how insurance coverage predicts how effective providers are at achieving ACO 
#19 measure attainment. My findings are the source of truth under the positivist ontology 
for my study 
My study is influenced by multiple contexts. The personal contexts for my study 
include my knowledge and experience with advance payment models and patient 
engagement. The social contexts include CMS guidelines, the fluidity of US healthcare 
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policy, political climate, geographic locations, and local healthcare delivery priorities. 
Lastly, interpersonal contexts include Walden University dissertation committee 
representatives. 
The definition of “provider success” is precise and supports a quantitative 
ontology of positivism where there is one true reality (Burkholder et al., 2016). 
Positivism guided my cross-sectional quantitative study to answer the question; “How 
effective were providers at influencing patient behavior based on the performance 
measure ACO #19 of the Medicaid Shared Savings Plan?”. I analyzed archival data from 
the CMS to support the positivist approach to my research question (Burkholder et al., 
2016).  
Background 
Colorectal cancer (CRC) is a leading cause of death in the United States (Lloyd, 
2016). The Centers for Disease Control and Prevention estimated over 40,000 deaths 
attributed to colon cancer in 2016 (Bachman et al., 2018). The risk of CRC mortality can 
be reduced with early detection (Lloyd, 2016). Focused efforts to increase CRC screening 
led to a reduction of CRC related deaths in the last decade; yet, several disparities 
continue to exist across socioeconomic and racial/ethnic boundaries (Bromley et al., 
2015). Klabunde et al. (2015) reported that almost 25% of adults between 76 and 84 did 
not meet the U.S.  Preventative Services Task Force recommendations for CRC screening 
before the advent of Medicare ACOs. 
APMs were created to fight rising health care costs in the United States (Noble et 
al., 2014). ACOs are one of the advanced payment models designed to shift the focus of 
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healthcare services from a traditional fee for service structure to a value-based care 
model. CRC screening is a key focus and measurement of ACOs. The propensity for 
provider recommendations for appropriate screening based on the Preventative Services 
Task Force recommendations for CRC screening was very low before the advent of 
Medicare ACOs (Klabunde et al., 2015). Studies showed that socioeconomic status was a 
patient characteristic and determinant of CRC screening completion (Farrukh & 
Mayberry, 2019).  
Some ACO populations include underserved and vulnerable patients who are 
covered by Medicaid in addition to their Medicare coverage (Powers & Keohane, 2018). 
Researchers found that Medicaid patients experienced bias when they pursued CRC 
screening (Davis et al., 2017). For example, Nymo, Aabakken, and Lassen (2018) 
reported that Medicaid patients experienced longer wait times when they scheduled CRC 
screening procedures whereas more affluent patients were prioritized to enhance their 
patient experience and satisfaction. Thus, providers must be aware of both intentional and 
unintended bias when working with patients from different cultures and socioeconomic 
groups (Alspach, 2018). Other studies, however, suggested Medicaid patients received 
more opportunities for CRC screening as care coordination improved for dual eligible 
patients (Craver et al., 2018). In fact, Davis and colleagues (2019) found evidence that 
CRC screening increased for Oregon Medicaid patients who were enrolled in an ACO. 
However, their research observed an ACO structure designed exclusively for Medicaid 
patients (Davis et al., 2019). Evidence also showed that more ACOs were more likely to 
have formal partnerships with public health agencies where there were large numbers of 
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Medicaid patients and where residents were eligible for both Medicare and Medicaid 
(Costich, Scutchfield, & Ingram, 2015) 
Research further documented disproportionate racial and socioeconomic 
disparities and highlighted the diverse cultural requirements needed to influence patient 
behavior (Ashktorab et al., 2017; Bromley et al., 2015; Burnett-Hartman et al., 2016; 
Chablani et al., 2017). Many studies offered anecdotal patient interventions for patients 
not enrolled in APMs (Nathan et al., 2016; Singal et al., 2017; Slyne et al., 2017). 
Additionally, studies that focused on non-APM patient experiences reinforced culturally 
competent approaches based on diverse patient demographics (Alsayid et al., 2019; 
Brittain & Murphy, 2015; Chen et al., 2016).  
Fear was demonstrated to be a major influence for compliance by all patients, but 
particularly among blacks and Hispanics (Basch et al., 2016; Bromley et al., 2015; Hall et 
al., 2016; Kiviniemi et al., 2018; Mastrokostas et al., 2018). Fear emerged as fear of both 
fear of undergoing the procedure and fear of the procedure’s findings (Bromley et al., 
2015). Ineffective communication and perceived provider uncertainty also affected the 
patient decision-making process (Beverly et al., 2016). This was confounded by patients’ 
expectations of the provider (Alspach, 2018; Mast & Kadji, 2018). For example, patients 
with different socio-economic backgrounds had different expectations of the quality of 
care they should receive from providers (Mast & Kadji, 2018). As such, trust was 
demonstrated to be a contributing factor behind non-compliance of CRC screening for 
Hispanic patients and patients of lower socio-economic status (Hong et al., 2018). Studies 
120 
 
also showed unconscious bias by providers when treating patients of different 
demographics and socioeconomic status (Williams et al., 2015). 
Medicare recognizes four methods of colonoscopy screening to demonstrate 
compliance with the ACO #19 measure (Prince et al., 2017). These include colonoscopy, 
DNA, stool testing, and fecal occult blood test. Studies suggest CRC compliance varies 
with the type of test offered, Thus, could impact the CRC screening recommendations 
that providers make to their patients (Alsayid et al., 2019; Basch et al., 2016; Bian et al., 
2016; Brenner & Chen, 2017; Bromley et al., 2015; Chambers et al., 2016). 
Colonoscopy is the most popular forms of CRC screening, and includes multiple 
steps like scheduling, bowel preparation, sedation, and the procedure itself; some of 
which contain multiple levels of compliance (Powers et al., 2018). For example, 
strategies such as enhanced written education, media campaigns, and videos improve 
compliance with the bowel preparation step (Andrealli et al., 2018; Cole et al., 2019; 
Essink-Bot et al., 2016). However, they were demonstrated as less effective to improve 
patient health literacy and compliance for completing a colonoscopy procedure (Clark et 
al., 2017; Enard et al., 2015; Mishra et al., 2018).  
Success varied among the experimental APMs in the United States (Noble et al., 
2014). Hibbard et al. (2015) documented that compensation from APMs in other 
countries influenced physician opinions on the importance of patient behavior. They 
further provided evidence that patient behavior was the primary driver of improving 
quality (Hibbard et al., 2015). Other studies showed that improvements in patient 
engagement lead to better health outcomes (Simmons et al., 2014; Grand et al., 2014). 
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Physicians in the United States agreed that patient behavior was the key 
determinant to improve quality and outcomes, yet, many found frustration when they 
tried to influence individual behavior (Hibbard et al., 2015). While many providers 
perceived their role within the community and in population health as “medicine-based”; 
a growing emphasis on preventative care and the diverse characteristics of their attributed 
patient base fostered better collaboration between healthcare providers and traditional 
public health organizations (Ingram et al., 2015). This was particularly true for mutual 
objectives like cancer prevention or serving a large number of Medicaid patients (Basch 
et al., 2016; Ingram et al., 2015).  
Nywelde et al. (2015) showed the initial performance under the Medicare ACO 
model reduced healthcare expenditures within the attributed population base when 
compared to traditional Medicare fee-for-service beneficiaries. The CMS measures ACO 
providers across four domains, which include care coordination, patient safety, patient 
experience, and preventative health (Modi et al., 2018). Providers are rewarded for the 
decreased cost of patient care as well as achieving various quality metrics outlined in 
their ACO contracts.  
Studies documented provider perceptions of barriers and provider characteristics 
that influenced their decision making and level success (Mastrokostas et al., 2018; Wang 
et al., 2018). These included the basic ability to verify patient’s correct CRC status and 
the clinician’s ability to confer with specialists (Mastrokostas et al., 2018) For example, a 
provider recommendation is a primary influence on whether patients of all demographic 
groups participate in CRC screenings (Bian et al., 2016; Bromley et al., 2015). Some 
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studies showed that health information technologies that shared patient information, 
insurance information and alerted providers to the patient’s CRC risk or screening status 
nudged providers to provide CRC screening recommendations (Kim et al., 2017b; 
Mankaney et al., 2019). Additionally, other studies reiterated the importance of Patient 
Behavior on quality performance and the need to implement systems to support patient 
engagement activities to influence behavior (Mishra et al., 2018). These included the 
concepts of, motivational interviewing, goal setting, and shared decision making (Mishra 
et al., 2018). However, Mishra et al. (2018) reported that providers were aware of these 
concepts but often lacked the depth of understanding and practice to implement them in a 
meaningful way. Shapiro et al. (2018) further described provider experiences with tough 
to manage patients in which providers described themselves as anxious, frustrated, and 
uncertain with little preparation for how to handle difficult patients. My study fills a gap 
in research by focusing on the patient insurance coverage to achieve compliance with 
CRC screening recommendations. 
Research Question and Design 
The nature of the manuscript is a cross-sectional quantitative study for the 
following research question:  
Based on the performance measures of the MSSP, what is the relationship 
between insurance and compliance of MSSP performance measure ACO #19? 
H0: There are no statistically significant differences in behavior as measured by 
the compliance of MSSP performance measure ACO #19 based on insurance coverage. 
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Ha: There are statistically significant differences in behavior as measured by the 
compliance of MSSP performance measure ACO #19 based on insurance coverage. 
The rationale for these research questions are based on a series of assumptions. 
First, there are outcomes related to patient behavior that are reported by CMS. Second, 
there are outcomes related to patient behavior that are perceived by physicians (Ravitch 
et al., 2016). Third, success can be measured through CMS reporting (CMS, 2017).  
Cross-sectional quantitative studies are descriptive research to describe 
community characteristics at a single point in time. I analyzed data from the MSSP PUF 
from 2019. I assessed the relationship of dependent variable ACO performance for 
measure ACO #19 and the independent variable patient insurance.  
Methods 
Operational Definitions 
ACO #19: Percentage of adults between 50–75 years of age who had appropriate 
screening for CRC for ACO quality reporting (CMS, 2017). 
Alternative payment delivery models: Several experimental advance/APMs have 
been created with varying success to introduce new patient engagement initiatives to 
combat higher U.S. healthcare costs (Noble et al., 2014). 
Attribution: The patients assigned to the health care provider for which they are 
being measured (Noble et al., 2014). 
Patient engagement: Studies show that improvements in patient engagement lead 
to better health outcomes (Simmons et al., 2014). 
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Practice size: The number of patients and the number of primary care physicians 
in an ACO. 
Bias and Limitations 
I analyzed archived data from the CMS; therefore, the quality of this quantitative 
data source was beyond my control as the researcher and contingent on the data 
collection process for MSSP reporting (Burkholder et al., 2016). CMS (2017) allows 
providers to review and dispute published performance data, followed by a final CMS 
ruling. I used the final report issued by CMS which included corrections to improve data 
quality. I coalso uld not control confounding variables that may influence provider-
patient attribution (Noble et al., 2014). These included patient comorbidities that can 
affect patients abilities to comply with healthcare treatment plans (DeJean et al., 2013).  
Scope and Delimitations 
The MSSP ACO PUF details physician performance against 32 measures across 
four domains (CMS, n.d.). The results are the official CMS findings and used to pay 
provider incentives (Noble et al., 2014). Therefore, these measures are valid 
representations of physician performance. The scope of my study was to evaluate 
physicians’ performance against the CMS measurement for colon cancer screening “ACO 
#19”.  
I limited my target population to the subset of organizations that had previous 
experience with MSSP ACOs and those who reported data for the 2019 MSSP reporting 
year. Excluding first-year MSSP participants improved credibility by ensuring that 
providers in the sample had a baseline measurement that reflected their performance 
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better (Noble et al., 2016). Foo et al. (2017) showed disparities in provider-patient 
interactions may be influenced by the factors race and patient insurance coverage. 
Therefore, a third delimitation limited the participatn sample to those with a patient base 
with at least 10% non-White and accept both Medicaid and Medicare patients (CMS, 
2017). Succesful attainmnet of ACO #19 was detrmined by a score of at least 30% (CMS, 
2017). I differentiated  well-performing providers from poor performing using this 
recognized benchmark as a fourth delimitation (CMS, 2017).  
Design 
Positivism guided the cross-sectional quantitative study to answer the question, 
“How effective are providers at influencing patient behavior based on the performance 
measure ACO #19 of the Medicaid Shared Savings Plan?”  Archival data analysis from 
the CMS 2019 MSSP PUF supported the positivist approach to my research question. I 
used the quality performance data for healthcare providers reported in the PUF to 
determine their effectiveness at influencing patient behavior as it correlated to their 
practice size. 
Instrumentation 
Archival data from the MSSP PUF for 2019 was used for the data collection 
process. The MSSP ACO PUF was derived from a combination of provider claims and 
survey data. The PUF files are available for performance years 2013-2019. The PUF file 
included hundreds of variables, descriptions and performance measure outcomes. These 
included measures for six behavior related preventative measures. Performance measures 
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were captured as a percent of the total population where a higher score means higher 
performance for that measure. 
Provider incentives for MSSP ACOs were based on quantitative analysis of their 
performance against established benchmarks (Noble et al., 2014). As such the current 
reporting for the effectiveness of APMs is dichotomous as the providers did or did not 
meet their measurement objectives (CMS, n.d.). This clear determination of provider 
success supports a quantitative ontology of positivism in which there is one true reality 
(Burkholder et al., 2016). Furthermore, quantitative analysis of provider performance 
using MSSP public use data is an accepted practice among the healthcare community 
(Noble et al., 2016).  
Participants 
I limited the evaluation of provider performance  to organizations in the United 
States who had previous ACO experience prior to 2019 and who reported data for the 
2019 MSSP reporting year. Previous studies showed that providers treated patients 
differently according to sociodemographic characteristics (Foo et al., 2017; Manteuffel et 
al., 2014). Therefore, I restricted participants to ACOs with a patient base of at least 10% 
non-White and who accepted both Medicaid and Medicare patients. Furthermore, CMS 
set a minimum standard of 30% achievement to comply with MSSP guidelines. 





Archival data was reviewed from the MSSP PUF for 2019. I used data for new 
and returning ACO participants from the 2019 MSSP PUF. I described the extent that 
ACOs were successful with measure ACO #19. I uploaded the entire MSSP PUF 
database into SPSS v25 for review, analysis, and statistical testing.  
Quantitative Collection and Analysis 
I assessed how effective ACOs were at changing patient behavior. I described the 
extent that ACOs were successful at achieving colon cancer screening for measure ACO 
#19. I uploaded the entire 2019 MSSP PUF database into SPSS v25 for review, analysis, 
and statistical testing. I retained the native MSSP PUF document, which was uploaded 
multiple times with all statistical tests replicated to ensure integrity and reliability. I used 
Pearson Correlation and linear regression to determine if there was a significant 
relationship between ACO practice size and performance. The level of significance was 
set to 0.05.  
Results  
Based on the performance measures of the MSSP, what is the relationship 
between insurance coverage and compliance with MSSP performance measure ACO 
#19? 
H0: There are no statistically significant differences in compliance with MSSP 
performance measure ACO #19 based on insurance coverage. 
Ha: There are statistically significant differences in compliance with MSSP 




Archival data from the MSSP PUF (CMS, n.d.) for 2019 were assessed for 470 
ACOs. I calculated an additional variable to reflect the percentage of the total population 
by race, age, gender, and Medicaid status in Microsoft Excel. The modified file was then 
entered into SPSS version 25 to organize, code, and screen data. Data for ACO #19 score 
and practice size were recoded to ordinal categorical data. Values were calculated 
including frequency counts and percentages with SPSS. Descriptive data analysis was 
performed for frequencies for all ACOs.  
The final sample size was narrowed to 140 ACOs based on the inclusion and 
exclusion criteria for the study. These included previous experience in the MSSP 
program and an ACO #19 score of 30 or more, an attribution that was at least 10% non-
White. I performed statistical assumption tests for normal distribution, homoscedasticity, 
and linearity between dependent and independent variables before research question 
analysis. Table 14 summarizes the dependent, independent variables, and statistical 
analyses used to evaluate the research questions. 
Table 14 
 
Variables and Statistical Tests Used to Evaluate Research Questions 
Research Question 
Dependent 
Variable Independent Variable Analysis 
What is the relationship 
between insurance and 
compliance with MSSP 
performance measure ACO 
#19? 
ACO #19 Score 
Number of Medicaid Patients 





Note. ACO = accountable care organization 
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Descriptive Statistics for all ACOs 
Descriptive analysis for all (n = 470) ACOs and the target sample (n = 140) were 
conducted for ACO #19 performance and insurance. Table 15 shows the ACO #19 
performance with most organizations achieving between 50% and 90%. Performance for 
the target population aligned with the larger base with most organizations (n = 85) 
achieving between 70–89% followed by those between 50–69% (n = 47).  
Table 15 
 
ACO #19 Performance Range and Frequency 
 All ACOs   Target ACOs 
ACO #19 Score Frequency Percent   Frequency Percent  
0-29 4 0.9     
30-49 13 2.8   4 2.9 
50-69 157 33.4   47 33.6 
70-89 287 61.1   85 60.7 
90 to 100 9 1.9   4 2.9 
Total 470 100.0   140 100.0 
Note. ACO = accountable care organization 
Most ACOs had less than 200 primary care providers with the majority falling 
between 50–99 at roughly 22%. ACOs that did not report a score for ACO #19 (n = 4) 
were removed. Of the remaining (n = 466) there was a total of 9,918,470 patients. Table 
16 shows beneficiaries with Medicaid totaled 606,989 or six percent of total patients. The 
number of patients with Medicaid ranged from 67-17,981. 
Table 16 
 
Range and Percentage of Attribution Across all ACOs 
  Minimum Maximum Sum Percent 
Total Patients 2,193 239,924 9,918,470   
Medicaid Patients 67 17,981 606,989 6% 




The attribution of most ACOs in the target population was under 40,000 patients. 
Table 17 shows that over half of the ACOs carried an attribution of between 10,000 and 
39,999 followed by a range of 2,193 to 9,999 (27%).   
Table 17 
 
Range and Percentage of Attribution 
Attribution Range Frequency Percent  
0-9,999 38 27.1 
10,000-39,999 77 55.0 
40,000-79,999 19 13.6 
80,000 or more 6 4.3 
Total 140 100.0 
 
Tests of Assumptions  
I conducted assumption tests of the dependent variable ACO #19. The data were 
normally distributed and follow a normal distribution curve. The skewness and kurtosis 
tests for normal distribution should fall between the rage of ±2 and ±7 respectfully. The 
ACO #19 score data for skewness was -.287 and kurtosis was -.692. The Kolmogorov-
Smirnov test for normality was insignificant at .058. Figure 5 shows the normal Q-Q plot 





Normal Q-Q Plot for ACO #19 Performance 
 
Note. ACO = accountable care organization 
Inferential Statistics  
The Medicaid.gov website (2021) defines Medicaid as insurance coverage 
provided by states according to federal requirements for eligible low-income patients and 
people with disabilities. I found that insurance coverage of patients in an ACO statically 
influenced ACO #19 performance. Therefore, the null hypothesis that there was no 
relationship between insurance and ACO #19 performance was rejected. I used bivariate 
correlation to assess the relationship between the dependent variable ACO #19 
Performance and independent variables for insurance (Medicaid). These included the 
total of Medicaid patients and the percentage of Medicaid patients of the total population. 
Table 18 shows the number of non-Medicaid patients in an ACO had a positive 
correlation of .247 that was statistically significant with p = .003. The percentage of 
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patients in the ACO had negative correlation of -.357 that was statistically significant 
with p<0.05. 
Table 18 
















0.259 0.003 0.000  
N 140 140 140 140  
Note. ACO = accountable care organization. **. Correlation is significant at the 0.01 
level (2-tailed). 
 
Medicaid only accounted for six percent of the total (n = 466) of the total 
population. However, figure six shows ACOs in the target sample (n = 140) with higher 
percentages of Medicaid patients performed lower than those with less.  
Figure 5 
 
ACO #19 Score and percent of Medicaid 
 




I used linear regression to further analyze the correlations between ACO #19 
Performance and levels of insurance coverage within the ACO population. The 
relationship was statistically significant (F(3,136) = 8.12, p<.05). Insurance accounted 
for a 15.2% variance in ACO performance and an adjusted R2 of .133. ACO performance 
decreased B = -.001 as the number of Medicaid Patients in increased. Performance 
decreased by B = -.228 as the percent of Medicaid patients in the ACO increased. 
Discussion  
Interpretation 
My research correlates with previous research around physician influence on 
paitent behavior and patient compliance with physicina recommendations. For example, 
Klabunde et al. (2015) reported that almost 25% of adults between 76 and 84 did not 
meet the U.S. Preventative Services Task Force recommendations for CRC screening 
before the advent of Medicare ACOs. My findings showed that only four out of 470 
ACOs did not meet the minimum performance score of 30 for ACO #19. However, 36% 
of the 140 target ACOs scored under 70%.  
The first ACOs showed an increase in CRC screening for patients 65 years or 
older when compared to non-ACO patients or the start of the ACO model (Preston et al., 
2018); however, significant disparities for screening rates were found between White and 
Black or Hispanic ACO members (Bromley et al., 2015). Additionally, the trend to 
improve quality measures has not applied to ACOs in underserved communities nor 
among racial disparities (Bromley et al., 2015). My overarching study found that ACOs 
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with more Black and Hispanic patients did not perform as well for ACO #19. Other 
researchers have also found disparities in compliance among people with health behavior 
recommendations based on factors including insurance coverage (Kiviniemi et al., 2018; 
Manteuffel et al., 2014).  
Additionally, I found that higher numbers and percentages of Medicaid patients 
negatively affected ACO #19 performance. Medicaid is insurance coverage for eligible 
low-income patients. Thus, high number of Medicaid patients could indicate lower 
socioeconomic status of the ACO attribution. But caution should be made when 
generalizing these results as they were not calculated at the individual patient or provider 
level.  
Interpretation in the Context of the Socioecological Model 
My study was guided by the SEM. Under the SEM, provider performance is 
affected by factors that influence both their decision making and their effectiveness to 
change patient behavior (Rabarison et al., 2013). My study showed that participation in 
an ACO and practice size as total patients and number of minorities may influence 
provider effectiveness to change patient behavior. Furthermore, results demonstrated that 
factors related to the characteristics of their patients influences their effectiveness. 
Society/policy factors tied to creating ACOs and their CMS quality measurements (i.e., 
success defined by a score of at least 30 for ACO #19) are also influential. My study did 
not report findings related to race. However, my overarching research demonstrated that 




There are limitations to my study. First, I excluded new ACOs from the full 
analysis. Thus, the range of performance of the sample population (n = 140) may not 
reflect the distribution of the entire ACO base (n = 470). Nor may it reflect provider 
patient relationships for providers and patients that do not participate in ACOs. Caution 
should be used when generalizing these results for other applications. Second, the MSSP 
PUF file data are restricted to the variables within the data set. The file does not provide 
CRC screening results at the individual level for patients or providers. Thus, my findings 
are limited to generalizations about ACOs based on total number of providers, total 
number of patients, and percentages of patients with certain characteristics. As a result, I 
am unable to articulate differences in ACO #19 compliance at the individual patient and 
rely instead solely on the ACO #19 performance score. I am also unable to articulate 
difference at the individual provider level. Lastly, the MSSP PUF has a one-year delay in 
reporting. The results were provided before the significant change in care delivery due to 
the COVID-19 pandemic and may influence the generalizability for future applications.  
Implications 
My study supported previous research that showed the characteristics of the 
providers’ patient population affected their ability to influence patient behavior. It further 
demonstrated disparities among poor patient populations. It also supports evidence which  
suggested that lower socioeconomic patients and Medicaid patients experienced bias 
when they pursued CRC screening (Davis et al., 2017). This may call for a focus on 
cultural competency strategies to mediate intentional and unintended bias when working 
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with patients from lower socioeconomic groups (Alspach, 2018). ACOs are partnerships 
among care providers including public health organizations. Thus, ACOs should consider 
their care delivery strategies and policies for lower socioeconomic populations as to the 
eligibility for enrollment and the scope of benefits they receive.  
My study promotes positive social change by providing meaningful data to the 
public health and health care provider partnerships engaged in transforming healthcare 
from a transactional delivery system to an evidence-based system of value (Berenson et 
al., 2016). My study helps to decrease the prevalence of CRC and by doing so reduce the 
economic and quality of life burden for individuals suffering from the disease. Moreover, 
my study may help to reduce disparities for CRC screening and incidence of CRC among 
poor populations. It provides a foundation for population health initiatives beyond CRC 
related illness Thus, improving the wellbeing of communities and increase public health 
emergency preparedness. Thus, my study can improve public health and healthcare 
professionals’ ability to influence the behaviors and health outcomes of the community 
members they serve. This is a vital component of current efforts to screen for COVID-19, 
promote adoption of behaviors to slow the spread of COVID-19 and adoption of COVID-
19 vaccinations. 
The CMS (2012) stated that more than 70% of patients over the age of 65 have 
two or more chronic conditions. The management of patients with multiple chronic 
diseases is more difficult than in those suffering from a single condition (Wagner et al., 
2013). Wang et al., observed (2020) that elderly COVID-19 patients were among the 
137 
 
most severe to critical cases with a high rate of fatality. Thus, the results of my study 
apply to current efforts for high risk elderly patients, their providers, and communities. 
Cancer screening rates have declined due to the COVID-19 pandemic (Carethers 
et al., 2020).  The COVID-19 pandemic disproportionality affected poor and minority 
communities (Carethers et al.). As such, Carethers et al., posit that extended delays in 
cancer screening is expected to lead to increase cancer for all populations. This is 
expected to be elevated in minorities and lower socio-economic people. My findings 
offer insight as to which populations may be at greater risk based on their previous 
experience with CRC screening before the pandemic.  
Lastly, my study may offer guidance to public health and healthcare provider 
leaders on ways to train professionals better, reduce frustration, improve success and 
achieve higher levels of satisfaction in their work both in routine interventions and public 
health emergencies. 
Recommendations 
Several recommendations resulted for additional research from my study. 
Additional analysis should be conducted for further assessment of ACO #19 performance 
based on additional patient characteristics such as age, race and gender. Second, CRC 
screening is the most complex behavior measured for ACOs which include a variety of 
tests with multiple steps like colonoscopy screening. This contrasts with dichotomous 
behaviors like receiving a flu-vaccinations. I recommend future studies compare complex 
behaviors like CRC with dichotomous decision like influenza vaccination.  
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The study should also be replicated for all 470 ACO participants. This may 
provide insight on differences and similarities to new and experienced ACOs. The study 
should also include provider feedback using the Primary Care Provider Behavioral Health 
Intervention Survey. The original tool was designed to assess provider perceptions of 
factors that influence their intention to use interventions when treating children with 
mental health problems and can be modified for adults (Arora et al., 2016). 
Lastly the study should be replicated and expanded as a mixed methods 
explanatory sequential study. Mixed methods integrates open-ended qualitative data with 
closed-ended quantitative data from inquiry (Creswell, 2009). Mixed methods strategy is 
purpose-driven research to provide a more in-depth insight into how health professionals 
influence participant behavior (Creswell, 2009). Mixed methods can develop a more 
comprehensive understanding of changes needed for population engagement as well as 
understanding the process and outcomes of current patient engagement strategies 
(Creswell, 2009).  
Conclusion  
Health care delivery and public health have overlapping efforts like health 
screening activities for better health outcomes and to lower the burden of disease 
(Cunningham, et al., 2020). Partnerships between community-based organizations, health 
care delivery and public health organizations improve public health outcomes. Studies 




The MSSP ACO is partnership based advanced payment model designed to curb 
cost and improve patient outcomes for colon cancer among other disease measures. CRC 
is a leading cause of death in the United States, (Loyd, 2016) and more research is needed 
to determine the impact of MSSP ACO providers on CRC screening. 
Previous research found disparities in health behavior recommendation 
compliance among people based on insurance and socio-economic status. My 
quantitative study of 140 ACO participants sought to determine the relationship between 
Medicaid coverage and compliance with MSSP performance measure for colonoscopy 
screening ACO #19.  
My study supported previous research that showed the characteristics of the 
providers’ patient population affected their ability to influence patient behavior. It further 
demonstrated disparities among minority and poor patient populations. My study showed 
differences in performance based on the number and percentage of patients with 
Medicaid. Performance decreased as the number and percentage of patients increased. 
This aligned with previous research which showed ACOs in underserved or lower socio-
economic areas did not perform as well as their peers in other areas.  
My study addressed the gap in research and focused on the distribution of 
Medicaid patients in ACO patient populations. It contributes to positive social change by 
providing meaningful data to public health partnerships and policies that impact 
community health outcomes for lower socio-economic patients.  Therefore, the 
application of my findings can improve the ability of public health and healthcare 
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providers to predict their influence on behavior and health outcomes of the community 
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Part 3: Summary 
Integration of the Studies 
My three studies incorporated different social determinants of health as 
independent variables toward the same dependent variable—ACO success for CRC 
screening. Collectively, these studies provide a picture of how ACO structures and the 
characteristics of their attribution contribute to patient behavior. For instance, previous 
researchers have found disparities in compliance among people with health behavior 
recommendations based on age, race, gender, insurance coverage and the size of their 
providers’ practices (Kiviniemi et al., 2018; Manteuffel et al., 2014). My results also 
found disparities based on age, race, insurance coverage, and practice size as defined by 
the number of patients. Additionally, the results showed that the number of providers 
may not affect provider influence due to the collaborative nature of ACOs. Gender did 
not influence performance in my study. However, the nature of my data was beyond 
individual patients and warrants further exploration at the individual level. One 
observation was that the number of patients in an ACO had a positive correlation to ACO 
#19 performance. A quantitative follow up with primary care physicians may provide 
more rationale for this phenomenon. 
Broadly, the factors of my studies relate to the community and organizational 
levels of the SEM. This is in part because the MSSP public use file provided attribution 
level data rather than individual patient data. The policy level is nested in the rules and 
guidelines of ACO formation, participation in the MSSP ACO program, and other 
factors. As such, I recommend that future studies explore behavior and decision making 
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at the individual level for patients and providers. This may provide more depth of 
understanding of the provider and patient relationship. Furthermore, exploring the 
specific strategies to influence behavior can also provide meaningful data for anyone 
engaged in influencing behaviors related to public health. Provider experiences to engage 
community members in their ACO attribution with varying social determinants of health 
has not been fully explored. Thus, there is an inability to replicate best practices for 
population engagement, which could improve health outcomes, participant experiences, 
lower costs, and improve job satisfaction. 
The social change contributions for my studies may offer meaningful data to 
public health organization and health care provider partnerships. They may help decrease 
the prevalence of CRC and by doing so reduce the economic and quality of life burden 
for individuals suffering from the disease. Moreover, my studies may help to reduce 
disparities for CRC screening, incidence of CRC, and other poor health outcomes among 
vulnerable populations, thus improving the well-being of communities and increasing 
public health emergency preparedness. My studies may also offer guidance to both public 
health and healthcare provider leaders on ways to train professionals better, reduce 
frustration, improve success, and achieve higher levels of satisfaction in their work both 
in routine interventions and public health emergencies. 
Conclusion 
Health care delivery and public health have overlapping efforts like health 
screening activities for better health outcomes and lowering the burden of disease 
(Cunningham et al., 2020). Partnerships between community-based organizations, health 
156 
 
care delivery, and public health organizations improve public health outcomes. The 
MSSP ACO is a partnership-based advanced payment model designed to curb cost and 
improve patient outcomes for colon cancer among other disease measures. However, 
more research is needed to determine the impact of MSSP ACO providers on CRC 
screening. Additionally, studies have also shown that patient behavior is the key to 
improve quality and health outcomes (Mogre et al., 2019). 
My quantitative study of 140 ACO participants sought to determine the 
relationship between patient attribution and provider characteristics with performance 
measure for colonoscopy screening ACO #19 compliance. My findings correlate with 
previous research. My results showed that the number of primary care physicians in an 
ACO did not influence their ACO #19 score. Thus, primary care provider participation 
and collaboratoin in an ACO may mediate some of the contraints found in other studies 
on practice size and ACO performance. I found that ACOs with more patients performed 
better. However, performance declined as the number and percentage of non-White 
patients increased. This aligned with previous research that showed disparities across 
socioeconomic and racial/ethnic groups. I found further differences in performance based 
on age. Performance increased for ACOs with more patients between the age of 65-85 
years old and declined with higher numbers of patients below 65 years old and over 85. 
My study also found that performance decreased as the number and percentage of 
Medicaid patients increased. This aligned with previous research that showed ACOs in 
underserved or lower socioeconomic areas did not perform as well as their peers in other 
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areas. My results did not show a difference in performance based on the gender of the 
ACO population. 
My study addressed the gap in research and focused on providers’ abilities to 
influence APM participant behavior. The research contributes to positive social change 
by providing meaningful data to public health partnerships that impact community health 
outcomes. Thus, the application of my findings can improve the ability of public health 
and healthcare providers to influence the behaviors and health outcomes of the 
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